TW202334720A - Wavelength conversion film and display device including the same - Google Patents

Wavelength conversion film and display device including the same Download PDF

Info

Publication number
TW202334720A
TW202334720A TW111143158A TW111143158A TW202334720A TW 202334720 A TW202334720 A TW 202334720A TW 111143158 A TW111143158 A TW 111143158A TW 111143158 A TW111143158 A TW 111143158A TW 202334720 A TW202334720 A TW 202334720A
Authority
TW
Taiwan
Prior art keywords
wavelength conversion
conversion film
group
mmol
photoluminescent
Prior art date
Application number
TW111143158A
Other languages
Chinese (zh)
Inventor
蔡潔
郑世俊
傑弗瑞 漢默克
協 劉
丁新亮
汀莎 姚
伊安 薩斯卡
王鵬
Original Assignee
日商日東電工股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商日東電工股份有限公司 filed Critical 日商日東電工股份有限公司
Publication of TW202334720A publication Critical patent/TW202334720A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K59/00Integrated devices, or assemblies of multiple devices, comprising at least one organic light-emitting element covered by group H10K50/00
    • H10K59/30Devices specially adapted for multicolour light emission
    • H10K59/38Devices specially adapted for multicolour light emission comprising colour filters or colour changing media [CCM]
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1011Condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C09K2211/1033Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1055Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with other heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18Metal complexes
    • C09K2211/186Metal complexes of the light metals other than alkali metals and alkaline earth metals, i.e. Be, Al or Mg
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/80Constructional details
    • H10K50/85Arrangements for extracting light from the devices
    • H10K50/854Arrangements for extracting light from the devices comprising scattering means
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K59/00Integrated devices, or assemblies of multiple devices, comprising at least one organic light-emitting element covered by group H10K50/00
    • H10K59/80Constructional details
    • H10K59/875Arrangements for extracting light from the devices
    • H10K59/877Arrangements for extracting light from the devices comprising scattering means

Abstract

Described herein is an improved wavelength converting film with composite materials that have improved quantum efficiency and color gamut. The film includes narrow FWHM green and red emitting dyes.

Description

波長轉換膜及包含其之顯示裝置Wavelength conversion film and display device containing the same

本發明係關於波長轉換膜及包括其之發光顯示裝置。The present invention relates to a wavelength conversion film and a light emitting display device including the same.

光致發光物質為在吸收呈光或電形式之能量後發射光的材料。視形成光致發光物質及發光機制之組分而定,光致發光物質可分類為無機光致發光物質(或染料)、有機光致發光染料、奈米結晶光致發光物質及其類似者。Photoluminescent substances are materials that emit light after absorbing energy in the form of light or electricity. Depending on the components forming the photoluminescent substance and the luminescence mechanism, the photoluminescent substance can be classified into inorganic photoluminescent substances (or dyes), organic photoluminescent dyes, nanocrystalline photoluminescent substances and the like.

近期,已描述多種使用此類光致發光物質修改光源之光譜的嘗試。光致發光物質吸收來自光源之特定波長之光,將其轉換成可見光區域中具有較長波長之光,且發射該光。視光致發光物質之發光特性而定,所發射光之亮度、色純度、色域等可極大地增強。無機光致發光物質可藉由諸如硫醚、氧化物或氮化物之母體化合物以及活化劑離子形成,且可用於具有極佳物理及化學穩定性以及高色純度再現的高品質顯示設備。然而,缺點在於此等無機光致發光物質價格極高、光發射效率低且光在400 nm或更高之近紫外線或藍光區域中的發射受到限制。Recently, various attempts have been described to use such photoluminescent substances to modify the spectrum of light sources. Photoluminescent substances absorb light of a specific wavelength from a light source, convert it into light with a longer wavelength in the visible light region, and emit the light. Depending on the luminescence properties of the photoluminescent substance, the brightness, color purity, color gamut, etc. of the emitted light can be greatly enhanced. Inorganic photoluminescent materials can be formed from parent compounds such as thioethers, oxides, or nitrides and activator ions, and can be used in high-quality display devices with excellent physical and chemical stability and high color purity reproduction. However, the disadvantages are that such inorganic photoluminescent materials are extremely expensive, have low light emission efficiency and are limited in the emission of light in the near ultraviolet or blue light region of 400 nm or higher.

量子點技術已達成高水平之量子效率及色域。然而,基於鎘之量子點可具極大毒性且由於健康安全性問題而在許多國家受到限制。另外,一些量子點在將藍色LED光轉換成綠光或紅光時具有低得多的量子效率。此外,量子點在暴露於濕氣及氧氣時可具有低穩定性,通常需要昂貴之封裝製程。量子點之成本可能較高,因為可能難以在其生產期間控制尺寸均勻性。Quantum dot technology has achieved high levels of quantum efficiency and color gamut. However, cadmium-based quantum dots can be extremely toxic and are restricted in many countries due to health safety concerns. Additionally, some quantum dots have much lower quantum efficiency at converting blue LED light into green or red light. In addition, quantum dots can have low stability when exposed to moisture and oxygen, often requiring expensive packaging processes. Quantum dots can be costly because it can be difficult to control dimensional uniformity during their production.

因此,需要相對於量子點及其他現有含光致發光染料之膜具有高量子效率、高色域輸出及較低成本的新光致發光膜。Therefore, there is a need for new photoluminescent films with high quantum efficiency, high color gamut output, and lower cost relative to quantum dots and other existing films containing photoluminescent dyes.

一些實施例包括一種波長轉換膜,其包含:聚合物基質;第一光致發光染料,該第一光致發光染料吸收藍色波長光且嚴密地以半高寬小於40 nm之發射光譜發射綠色波長光;第二光致發光,該第二光致發光染料吸收藍色或綠色波長光且嚴密地以半高寬小於55 nm之發射光譜發射紅色波長光;及光散射中心;其中該第一光致發光染料、該第二光致發光染料及該光散射中心安置於該聚合物基質內。Some embodiments include a wavelength conversion film comprising: a polymer matrix; a first photoluminescent dye that absorbs blue wavelength light and emits strictly green with an emission spectrum with a half-maximum width less than 40 nm. wavelength light; a second photoluminescence, the second photoluminescence dye absorbs blue or green wavelength light and strictly emits red wavelength light with an emission spectrum with a half-maximum width less than 55 nm; and a light scattering center; wherein the first The photoluminescent dye, the second photoluminescent dye and the light scattering center are disposed within the polymer matrix.

在一些實施例中,該第一光致發光染料可包含視情況經取代之BODIPY基團、連接基團及視情況經取代之異喹啉基。在一些實施例中,該第一光致發光染料可為: (FD-1),及/或 (FD-3)。 In some embodiments, the first photoluminescent dye can include an optionally substituted BODIPY group, a linking group, and an optionally substituted isoquinolinyl group. In some embodiments, the first photoluminescent dye can be: (FD-1), and/or (FD-3).

在一些實施例中,該第一光致發光染料可包含視情況經取代之BODIPY基團、連接基團及視情況經取代之萘二甲酸醯亞胺基。在一些實施例中,該第一光致發光染料可為: (FD-2)。 In some embodiments, the first photoluminescent dye can include an optionally substituted BODIPY group, a linking group, and an optionally substituted naphthalenedicarboxylic acid imide group. In some embodiments, the first photoluminescent dye can be: (FD-2).

在一些實施例中,該第二光致發光染料可包含視情況經取代之BODIPY基團、連接基團及視情況經取代之異喹啉基。在一些實施例中,該第二光致發光染料可為: (SD-1), (SD-2),及/或 (SD-4)。 In some embodiments, the second photoluminescent dye can include an optionally substituted BODIPY group, a linking group, and an optionally substituted isoquinolinyl group. In some embodiments, the second photoluminescent dye can be: (SD-1), (SD-2), and/or (SD-4).

在一些實施例中,該第二光致發光染料可包含視情況經取代之BODIPY基團、連接基團及視情況經取代之萘二甲醯亞胺基。在一些實施例中,該第二光致發光染料可為: In some embodiments, the second photoluminescent dye can include an optionally substituted BODIPY group, a linking group, and an optionally substituted naphthalenedimide group. In some embodiments, the second photoluminescent dye can be: .

在一些實施例中,該第二光致發光染料可包含視情況經取代之BODIPY基團、連接基團及視情況經取代之苝基。在一些實施例中,該第二光致發光染料可包含: In some embodiments, the second photoluminescent dye can include an optionally substituted BODIPY group, a linking group, and an optionally substituted perylene group. In some embodiments, the second photoluminescent dye can include: .

在一些實施例中,該膜可具有大於80%之內部量子產率。在一些實施例中,該膜可具有大於50%之外部量子產率。在一些實施例中,該膜可具有大於BT.2020標準或Rec.2020標準之90%的色域。在一些實施例中,該膜可具有小於50微米之厚度。In some embodiments, the film can have an internal quantum yield greater than 80%. In some embodiments, the film can have an external quantum yield greater than 50%. In some embodiments, the film can have a color gamut greater than 90% of the BT.2020 standard or Rec.2020 standard. In some embodiments, the film may have a thickness of less than 50 microns.

一些實施例包括一種發光裝置,其包含本文所描述之光致發光波長轉換膜。Some embodiments include a light emitting device including a photoluminescent wavelength conversion film described herein.

一些實施例包括一種具有藍色光源之背光裝置,該裝置包含本文所描述之光致發光波長轉換膜。Some embodiments include a backlight device with a blue light source that includes a photoluminescent wavelength conversion film described herein.

下文更詳細地描述此等及其他實施例。These and other embodiments are described in greater detail below.

本發明係關於波長轉換膜,其包含具有高量子效率、高色域輸出及低成本的光致發光化合物(或染料)。The present invention relates to wavelength conversion films, which contain photoluminescent compounds (or dyes) with high quantum efficiency, high color gamut output and low cost.

如本文所用之術語「BODIPY」係指具有下式的視情況經取代之化學部分: , 其中虛線所指示之環為視情況存在的。 The term "BODIPY" as used herein refers to an optionally substituted chemical moiety having the formula: , where the ring indicated by the dotted line exists depending on the situation.

BODIPY部分包含與經二取代之硼原子(通常為BF 2單元)錯合的二吡咯亞甲基。BODIPY核心之IUPAC名稱為4,4-二氟-4-硼-3a,4a-二氮雜-s-二環戊二烯并苯。 The BODIPY moiety contains a dipyrromethene complexed to a disubstituted boron atom (usually a BF 2 unit). The IUPAC name of the core of BODIPY is 4,4-difluoro-4-boron-3a,4a-diaza-s-dicyclopentacene.

如本文所用之術語「苝」或「苝衍生物」係指具有下式的視情況經取代之化學部分: The term "perylene" or "perylene derivative" as used herein refers to an optionally substituted chemical moiety having the formula:

如本文所用之術語「萘二甲酸醯亞胺」或「萘二甲酸衍生物」係指具有下式的視情況經取代之化學部分: ,其中X = NR,其中R可為連接基團或芳基。 The term "naphthalenedicarboxylic acid imide" or "naphthalenedicarboxylic acid derivative" as used herein refers to an optionally substituted chemical moiety having the following formula: , where X = NR, where R can be a linking group or an aryl group.

如本文所用之術語「異喹啉」或「異喹啉衍生物」或「𠮿并異喹啉衍生物」係指具有下式的視情況經取代之化學部分: ,其中X = NR,其中R可為連接基團或芳基,且Y可為氫基、C 1-C 3烷基或芳基,例如苯甲基。 As used herein, the term "isoquinoline" or "isoquinoline derivative" or "isoquinoline" "isoquinoline derivative" means an optionally substituted chemical moiety having the following formula: , where

如本文所用之術語「萘二甲醯亞胺」或「萘二甲醯亞胺衍生物」係指具有下式的視情況經取代之化學部分: 其中R 0可為氫(H)、經取代或未經取代之芳基或CF 3,其中X可為氧(O)或硫(S),其中R 1可為氫、經取代或未經取代之芳基(諸如苯基、氟烷基苯基(例如4-三氟甲基苯基)等)或C 1-C 5烷基。 The term "naphthalenedimine" or "naphthalenedimine derivative" as used herein refers to an optionally substituted chemical moiety having the formula: where R 0 can be hydrogen (H), substituted or unsubstituted aryl or CF 3 , where X can be oxygen (O) or sulfur (S), where R 1 can be hydrogen, substituted or unsubstituted Aryl group (such as phenyl, fluoroalkylphenyl (such as 4-trifluoromethylphenyl), etc.) or C 1 -C 5 alkyl group.

在一些實施例中,BODIPY部分藉由連接基團連接至苝部分。在一些實施例中,BODIPY部分藉由連接基團連接至萘二甲酸醯亞胺部分。在一些實施例中,BODIPY部分藉由連接基團連接至異喹啉部分。在一些實施例中,BODIPY部分藉由連接基團連接至萘二甲醯亞胺部分。In some embodiments, the BODIPY moiety is linked to the perylene moiety via a linking group. In some embodiments, the BODIPY moiety is linked to the naphthalenedicarboxylic acid imine moiety via a linking group. In some embodiments, the BODIPY moiety is linked to the isoquinoline moiety via a linking group. In some embodiments, the BODIPY moiety is linked to the naphthalenedimine moiety via a linking group.

使用術語「可(may)」或「可為(may be)」應視為「為(is)」或「不為(is not)」或替代地「確實(does)」或「不(does not)」或「將(will)」或「將不(will not)」等之簡寫。舉例而言,表述「膜可包含安置於聚合物基質內之散射中心」應解譯為例如「在一些實施例中,膜包含安置於聚合物基質內之散射中心」或「在一些實施例中,膜不包含安置於聚合物基質內之散射中心」。Use of the terms "may" or "may be" shall be taken to mean "is" or "is not" or alternatively "does" or "does not" )" or "will (will)" or "will not (will not)", etc. For example, the statement "the film may comprise a scattering center disposed within a polymeric matrix" should be interpreted to mean, for example, "In some embodiments, the film comprises a scattering center disposed within a polymeric matrix" or "In some embodiments , the film does not contain scattering centers disposed within the polymer matrix".

術語ITU-R建議書BT.2020 (更常以縮寫Rec.2020或BT.2020知曉)係指色域之彩色顯示標準。Rec.2020所用之RGB原色相當於CIE 1931光譜軌跡上之單色光源。Rec.2020原色之波長如下:紅色原色為630 nm,綠色原色為532 nm,且藍色原色為467 nm。Rec.2020色彩空間覆蓋CIE 1931色彩空間之75.8% (經判定三角形內之面積)。Rec.2020使用CIE標準照明體D65作為白點及以下色彩座標:Xw = 0.3127;Yw = 0.3290;XR = 0.708,YR = 0.292,XG = 0.17,YG = 0.797;XB = 0.131;YB = 0.046。The term ITU-R Recommendation BT.2020 (more commonly known by the abbreviation Rec.2020 or BT.2020) refers to the color display standard for color gamut. The RGB primary colors used in Rec.2020 are equivalent to monochromatic light sources on the CIE 1931 spectral locus. The wavelengths of the Rec.2020 primary colors are as follows: the red primary color is 630 nm, the green primary color is 532 nm, and the blue primary color is 467 nm. The Rec.2020 color space covers 75.8% of the CIE 1931 color space (the area within the determined triangle). Rec.2020 uses CIE standard illuminant D65 as the white point and the following color coordinates: Xw = 0.3127; Yw = 0.3290; XR = 0.708, YR = 0.292, XG = 0.17, YG = 0.797;

一些實施例包括一種波長轉換膜,其包含聚合物基質、第一有機光致發光化合物及第二有機光致發光化合物。在一些實施例中,膜可包含發射綠光且具有半高寬小於30 nm或40 nm之發射峰的第一有機光致發光染料。在一些實施例中,膜可包含發射紅光且具有半高寬小於55 nm之發射峰的第二有機光致發光染料。在一些實施例中,膜可包含光散射中心。在一些實例中,第一有機光致發光染料(發射綠光)、第二有機光致發光染料(發射紅光)及散射中心安置於聚合物基質內。在一些實施例中,膜提供高量子產率。在一些實施例中,膜提供大於90%之廣色域。用以判定色域百分比之適合手段為量測所產生之1931 CIE色彩空間下之面積。在一些實施例中,膜可介於89%與99.9%色域之間,例如91-92%、92-93%、93-94%、98-99.9%、89-93%、93-96%及/或96-99.9%,或由任何此等值限定之範圍。一些實施例包括一種LCD背光,其包含前述膜。Some embodiments include a wavelength converting film including a polymer matrix, a first organic photoluminescent compound, and a second organic photoluminescent compound. In some embodiments, the film may include a first organic photoluminescent dye that emits green light and has an emission peak with a half-maximum width less than 30 nm or 40 nm. In some embodiments, the film may include a second organic photoluminescent dye that emits red light and has an emission peak with a half-maximum width less than 55 nm. In some embodiments, the film may contain light scattering centers. In some examples, a first organic photoluminescent dye (emitting green light), a second organic photoluminescent dye (emitting red light), and a scattering center are disposed within a polymer matrix. In some embodiments, the membrane provides high quantum yield. In some embodiments, the film provides greater than 90% of a wide color gamut. A suitable means of determining color gamut percentage is to measure the area under the resulting 1931 CIE color space. In some embodiments, the film can be between 89% and 99.9% of the color gamut, such as 91-92%, 92-93%, 93-94%, 98-99.9%, 89-93%, 93-96% and/or 96-99.9%, or a range limited by any such value. Some embodiments include an LCD backlight including the aforementioned film.

在一些實施例中,膜可包含聚合物基質。在一些實施例中,聚合物基質可具有大於75%、大於80%、大於90%或大於95%之透明度。在一些實施例中,聚合物基質可包含親水性或疏水性聚合物。在一些實施例中,聚合物基質可包含聚乙烯醇縮丁醛、聚乙酸乙烯酯、聚乙烯醇或聚丙烯酸酯。在一些實施例中,聚合物基質可包含聚乙烯醇縮丁醛(PVB)。在一些實施例中,聚丙烯酸酯可為聚烷基丙烯酸酯。在一些實施例中,聚烷基丙烯酸酯可為聚甲基丙烯酸甲酯(PMMA)。In some embodiments, the membrane may comprise a polymer matrix. In some embodiments, the polymer matrix can have a transparency of greater than 75%, greater than 80%, greater than 90%, or greater than 95%. In some embodiments, the polymer matrix may include hydrophilic or hydrophobic polymers. In some embodiments, the polymer matrix may include polyvinyl butyral, polyvinyl acetate, polyvinyl alcohol, or polyacrylate. In some embodiments, the polymer matrix may include polyvinyl butyral (PVB). In some embodiments, the polyacrylate can be a polyalkyl acrylate. In some embodiments, the polyalkyl acrylate can be polymethylmethacrylate (PMMA).

在一些實施例中,光致發光化合物(及/或包含光致發光化合物之光致發光波長轉換膜)具有窄吸收或發射帶,使得發射少量可見光波長光。吸收或發射帶可由半高寬(FWHM)表徵。在本發明中,FWHM界定吸收或發射光譜在吸收或發射峰波長之一半處的以奈米為單位之寬度。在一些實施例中,光致發光化合物在分散於大體上透明之聚合物基質中時具有FWHM值小於或等於50 nm、小於或等於40 nm、小於或等於35 nm、小於或等於30 nm或小於或等於25 nm的吸收帶。在一些實施例中,光致發光化合物在分散於大體上透明之聚合物基質中時具有FWHM值小於或等於50 nm、小於或等於40 nm、小於或等於35 nm或小於或等於30 nm的發射帶。In some embodiments, the photoluminescent compound (and/or the photoluminescent wavelength conversion film including the photoluminescent compound) has a narrow absorption or emission band such that a small amount of visible wavelength light is emitted. The absorption or emission band can be characterized by the full width at half maximum (FWHM). In the present invention, FWHM defines the width in nanometers of an absorption or emission spectrum at half the absorption or emission peak wavelength. In some embodiments, the photoluminescent compound has a FWHM value less than or equal to 50 nm, less than or equal to 40 nm, less than or equal to 35 nm, less than or equal to 30 nm, or less than or an absorption band equal to 25 nm. In some embodiments, the photoluminescent compound has an emission with a FWHM value less than or equal to 50 nm, less than or equal to 40 nm, less than or equal to 35 nm, or less than or equal to 30 nm when dispersed in a substantially transparent polymer matrix. belt.

在一些實施例中,膜可包含第一有機光致發光化合物(或染料)。在一些實施例中,第一有機光致發光染料(及/或包含第一有機光致發光染料之光致發光波長轉換膜)可具有510與520 nm或520與530 nm之間,或由任何此等值所限定的範圍內的放射峰(發射綠光)。在一些實施例中,第一有機光致發光染料及/或光致發光波長轉換膜之發射光譜可具有小於35 nm、小於30 nm或小於20 nm之半高寬(FWHM)。In some embodiments, the film may include a first organic photoluminescent compound (or dye). In some embodiments, the first organic photoluminescent dye (and/or the photoluminescent wavelength conversion film including the first organic photoluminescent dye) may have a wavelength between 510 and 520 nm or between 520 and 530 nm, or by any The emission peak (emitting green light) within the range defined by these equivalent values. In some embodiments, the emission spectrum of the first organic photoluminescent dye and/or the photoluminescent wavelength conversion film may have a full width at half maximum (FWHM) of less than 35 nm, less than 30 nm, or less than 20 nm.

在一些實施例中,第一有機光致發光染料可包含視情況經取代之BODIPY基團、連接基團及視情況經取代之異喹啉基。在一些實施例中,視情況經取代之異喹啉基可為視情況經取代之異喹啉衍生物基團。在一些實施例中,視情況經取代之異喹啉基可為視情況經取代之𠮿并異喹啉衍生物基團。在一些實施例中,視情況經取代之BODIPY基共價鍵結至連接基團。在其他實施例中,連接基團共價鍵結至視情況經取代之異喹啉基。在其他實施例中,連接基團共價鍵結至視情況經取代之異喹啉衍生物基團。在其他實施例中,連接基團共價鍵結至視情況經取代之𠮿異喹啉衍生物基團。In some embodiments, the first organic photoluminescent dye can include an optionally substituted BODIPY group, a linking group, and an optionally substituted isoquinolinyl group. In some embodiments, the optionally substituted isoquinolyl group can be an optionally substituted isoquinoline derivative group. In some embodiments, the optionally substituted isoquinolinyl group can be the optionally substituted isoquinolyl group And isoquinoline derivative group. In some embodiments, the optionally substituted BODIPY group is covalently bonded to the linking group. In other embodiments, the linking group is covalently bonded to an optionally substituted isoquinolinyl group. In other embodiments, the linking group is covalently bonded to an optionally substituted isoquinoline derivative group. In other embodiments, the linking group is covalently bonded to an optionally substituted Isoquinoline derivative group.

在一些實施例中,第一有機光致發光染料可包含視情況經取代之BODIPY基團、連接基團及視情況經取代之萘二甲酸醯亞胺基。在一些實施例中,視情況經取代之萘二甲酸醯亞胺基可為視情況經取代之萘二甲酸衍生物基團。在一些實施例中,視情況經取代之BODIPY基共價鍵結至連接基團。在其他實施例中,連接基團共價鍵結至視情況經取代之萘二甲酸醯亞胺基。在其他實施例中,連接基團共價鍵結至視情況經取代之萘二甲酸衍生物基團。In some embodiments, the first organic photoluminescent dye can include an optionally substituted BODIPY group, a linking group, and an optionally substituted naphthalenedicarboxylic acid imide group. In some embodiments, the optionally substituted naphthalenedicarboxylic acid imide group may be an optionally substituted naphthalenedicarboxylic acid derivative group. In some embodiments, the optionally substituted BODIPY group is covalently bonded to the linking group. In other embodiments, the linking group is covalently bonded to an optionally substituted naphthalenedicarboxylic acid imide group. In other embodiments, the linking group is covalently bonded to an optionally substituted naphthalenedicarboxylic acid derivative group.

在一些實施例中,第一有機光致發光染料可選自以下同在申請中的申請案中所描述之光致發光染料:2021年2月22日申請之美國臨時申請案第63/152,309號,其關於光致發光染料之論述以引用之方式併入本文中;及2021年11月12日申請之美國臨時申請案第63/278,904號,代理人案號N3253.10133US02,以引用之方式併入本文中。In some embodiments, the first organic photoluminescent dye can be selected from the photoluminescent dyes described in the following co-pending application: U.S. Provisional Application No. 63/152,309, filed February 22, 2021 , whose discussion of photoluminescent dyes is incorporated herein by reference; and U.S. Provisional Application No. 63/278,904, filed on November 12, 2021, Attorney Docket No. N3253.10133US02, are incorporated by reference. into this article.

在一些實施例中,第一有機光致發光染料可選自FD-1、FD-2或FD-3: (FD-1), (FD-2), (FD-3),或其組合。 In some embodiments, the first organic photoluminescent dye can be selected from FD-1, FD-2, or FD-3: (FD-1), (FD-2), (FD-3), or combinations thereof.

在一些實施例中,波長轉換膜可包含第二有機光致發光染料。在一些實施例中,第二有機光致發光染料(及/或包含第二有機光致發光染料之光致發光波長轉換膜)可具有400與470 nm之間的吸收峰(吸收藍光)。在一些實施例中,第二有機光致發光染料(及/或包含第二有機光致發光染料之光致發光波長轉換膜)可具有610與620 nm或620與630 nm之間,或由任何此等值所限定之範圍內的發射峰(發射紅光)。在一些實施例中,第二有機光致發光染料及/或光致發光波長轉換膜之發射光譜可具有小於65 nm、55 nm、50 nm、45 nm、小於40 nm或小於35 nm之半高寬(FWHM)。In some embodiments, the wavelength conversion film may include a second organic photoluminescent dye. In some embodiments, the second organic photoluminescent dye (and/or the photoluminescent wavelength conversion film including the second organic photoluminescent dye) may have an absorption peak between 400 and 470 nm (absorbing blue light). In some embodiments, the second organic photoluminescent dye (and/or the photoluminescent wavelength conversion film including the second organic photoluminescent dye) may have a wavelength between 610 and 620 nm or between 620 and 630 nm, or by any The emission peak (red light emission) within the range defined by these equivalent values. In some embodiments, the emission spectrum of the second organic photoluminescent dye and/or the photoluminescent wavelength conversion film may have a half-height of less than 65 nm, 55 nm, 50 nm, 45 nm, less than 40 nm, or less than 35 nm. Width (FWHM).

在一些實施例中,第二有機光致發光染料可包含BODIPY基團、連接基團及苝基。在一些實施例中,苝基可為苝衍生物基團。在一些實施例中,BODIPY基團共價鍵結至連接基團。在其他實施例中,連接基團共價鍵結至苝基。在其他實施例中,連接基團共價鍵結至苝衍生物基團。In some embodiments, the second organic photoluminescent dye can include a BODIPY group, a linking group, and a perylene group. In some embodiments, the perylene group can be a perylene derivative group. In some embodiments, the BODIPY group is covalently bonded to the linking group. In other embodiments, the linking group is covalently bonded to the perylene group. In other embodiments, the linking group is covalently bonded to the perylene derivative group.

在一些實施例中,第二有機光致發光染料可包含BODIPY基團、連接基團及異喹啉基。在一些實施例中,異喹啉基可為異喹啉衍生物基團。在一些實施例中,BODIPY基團共價鍵結至連接基團。在其他實施例中,連接基團共價鍵結至異喹啉基。在其他實施例中,連接基團共價鍵結至異喹啉衍生物基團。In some embodiments, the second organic photoluminescent dye can include a BODIPY group, a linking group, and an isoquinolinyl group. In some embodiments, the isoquinolyl group can be an isoquinoline derivative group. In some embodiments, the BODIPY group is covalently bonded to the linking group. In other embodiments, the linking group is covalently bonded to the isoquinolinyl group. In other embodiments, the linking group is covalently bonded to the isoquinoline derivative group.

在一些實施例中,第二有機光致發光染料可包含BODIPY基團、連接基團及萘二甲醯亞胺基。在一些實施例中,萘二甲醯亞胺基可為萘二甲醯亞胺衍生物基團。在一些實施例中,BODIPY基團共價鍵結至連接基團。在其他實施例中,連接基團共價鍵結至萘二甲醯亞胺基。在其他實施例中,連接基團共價鍵結至萘二甲醯亞胺衍生物基團。In some embodiments, the second organic photoluminescent dye can include a BODIPY group, a linking group, and a naphthalenedimide group. In some embodiments, the naphthalenedimine group can be a naphthalenedimine derivative group. In some embodiments, the BODIPY group is covalently bonded to the linking group. In other embodiments, the linking group is covalently bonded to the naphthalenedimine group. In other embodiments, the linking group is covalently bonded to the naphthalenedimine derivative group.

在一些實施例中,第一有機光致發光染料可選自以下同在申請中的申請案中所描述之光致發光染料:2021年9月27日申請之美國臨時申請案第63/248,863號,其關於光致發光染料之論述以引用之方式併入本文中;2021年11月19日申請之美國臨時申請案第63/278,904號,代理人案號N3252.10147US02,以引用之方式併入本文中;及PCT專利公開案WO2020/210761,以引用之方式併入本文中。在一些實施例中,第二有機光致發光染料可選自SD-1、SD-2、SD-3、SD-4或SD-5: (SD-1), (SD-2), (SD-3), (SD-4), ,或其組合。 In some embodiments, the first organic photoluminescent dye can be selected from the photoluminescent dyes described in the following co-pending application: U.S. Provisional Application No. 63/248,863, filed September 27, 2021 , whose discussion of photoluminescent dyes is incorporated herein by reference; U.S. Provisional Application No. 63/278,904, filed on November 19, 2021, Attorney Docket No. N3252.10147US02, is incorporated by reference. herein; and PCT Patent Publication WO2020/210761, are incorporated herein by reference. In some embodiments, the second organic photoluminescent dye can be selected from SD-1, SD-2, SD-3, SD-4 or SD-5: (SD-1), (SD-2), (SD-3), (SD-4), , or a combination thereof.

在一些實施例中,第一光致發光化合物可吸收UV/藍光吸收光譜內之光且發射綠光發射光譜內之光,從而增強感知到之所發射綠光。在其他實施例中,第二光致發光化合物可吸收綠光及/或藍光吸收光譜內之光且發射紅光發射光譜內之光,從而增強感知到之所發射紅光。在一些實施例中,第一及第二光致發光染料可吸收UV/藍光吸收光譜內之光且發射其他波長之光,其中所得組合光可感知為白光。在一些實例中,所感知之白光可具有描述為涼的色溫。在一些實施例中,所感知之白光可具有描述為溫之色溫。In some embodiments, the first photoluminescent compound can absorb light in the UV/blue absorption spectrum and emit light in the green emission spectrum, thereby enhancing the perception of the emitted green light. In other embodiments, the second photoluminescent compound can absorb light in the green and/or blue absorption spectrum and emit light in the red emission spectrum, thereby enhancing the perception of the emitted red light. In some embodiments, the first and second photoluminescent dyes can absorb light within the UV/blue light absorption spectrum and emit light at other wavelengths, where the resulting combined light can be perceived as white light. In some examples, perceived white light may have a color temperature described as cool. In some embodiments, perceived white light may have a color temperature described as warm.

在一些實施例中,第一光致發光染料及第二光致發光染料可吸收發射藍光光譜內之光的光源之約60-70%。在一些實施例中,所得白光包含30-50%藍光、自波長轉換膜發射之20-30%紅光及自波長轉換膜發射之20-30%綠光。可調整膜之厚度以調節由波長轉換膜吸收之藍光之百分比及穿過波長轉換膜以包含所得白光之藍光之百分比。在一些實施例中,光致發光波長轉換膜可具有任何適合厚度,諸如小於約500 µm、小於約200 µm或小於約100 µm,諸如約1-20 µm、約10-40 µm、約20-30 µm、約30-40 µm、約40-50 µm、約50-80 µm、約80-120 µm、約120-200 µm、約200-300 µm或約300-500 µm。In some embodiments, the first photoluminescent dye and the second photoluminescent dye can absorb about 60-70% of a light source emitting light in the blue spectrum. In some embodiments, the resulting white light includes 30-50% blue light, 20-30% red light emitted from the wavelength conversion film, and 20-30% green light emitted from the wavelength conversion film. The thickness of the film can be adjusted to adjust the percentage of blue light absorbed by the wavelength conversion film and the percentage of blue light that passes through the wavelength conversion film to contain the resulting white light. In some embodiments, the photoluminescent wavelength conversion film can have any suitable thickness, such as less than about 500 µm, less than about 200 µm, or less than about 100 µm, such as about 1-20 µm, about 10-40 µm, about 20- 30 µm, about 30-40 µm, about 40-50 µm, about 50-80 µm, about 80-120 µm, about 120-200 µm, about 200-300 µm or about 300-500 µm.

在一些實施例中,波長轉換膜之厚度可根據比爾-朗伯定律減小或增大。尤其,比爾-朗伯定律可用於推導膜厚度與第一光致發光染料及第二光致發光染料之濃度之間的關係,以獲取自光源發射之60-70%之藍光。在一些實施例中,染料濃度可降低,且厚度可增大以准許吸收60-70%之藍光。在一些實施例中,染料濃度可升高,且厚度可減小,以准許吸收60-70%之藍光。在一些實施例中,針對下文實例章節之表1中所示之大部分染料濃度,光致發光波長轉換膜可具有大於20 µm且小於30 µm之適合厚度。In some embodiments, the thickness of the wavelength conversion film may decrease or increase according to Beer-Lambert's law. In particular, the Beer-Lambert law can be used to derive the relationship between the film thickness and the concentration of the first photoluminescent dye and the second photoluminescent dye to obtain 60-70% of the blue light emitted from the light source. In some embodiments, the dye concentration can be reduced and the thickness increased to allow for 60-70% absorption of blue light. In some embodiments, the dye concentration can be increased and the thickness reduced to allow for 60-70% absorption of blue light. In some embodiments, the photoluminescent wavelength conversion film may have a suitable thickness greater than 20 µm and less than 30 µm for most of the dye concentrations shown in Table 1 of the Examples section below.

在一些實施例中,連接基團之長度可經調節以使第一光致發光染料及第二光致發光染料之溶解度最佳化。在一些實施例中,第一光致發光染料及第二光致發光染料之溶解度可大於0.15%。在一些實施例中,第一光致發光染料及第二光致發光染料之溶解度可為約.03%-0.8%、約0.8%-2%或約2%-3%,或任何以上值所限定之範圍內的溶解度。In some embodiments, the length of the linking group can be adjusted to optimize the solubility of the first photoluminescent dye and the second photoluminescent dye. In some embodiments, the solubility of the first photoluminescent dye and the second photoluminescent dye can be greater than 0.15%. In some embodiments, the solubility of the first photoluminescent dye and the second photoluminescent dye may be about .03%-0.8%, about 0.8%-2%, or about 2%-3%, or any of the above values. solubility within a limited range.

可調整第一光致發光染料與第二光致發光染料之量的比率以調節光致發光波長轉換膜之色彩特性。舉例而言,第一光致發光染料與第二光致發光染料之重量比可為約0.01-100 (1 mg第一光致發光染料與100 mg第二光致發光染料之比率為0.01)、約0.01-0.2、約0.2-0.4、約0.4-0.6、約0.6-0.8、約0.8-1、約1-2、約2-3、約3-4、約4-5、約5-6、約6-7、約7-8、約8-9、約9-10、約10-20、約20-40、約40-70、約70-100、約0.43、約0.91、約1.8或約3.0。The ratio of the amounts of the first photoluminescent dye and the second photoluminescent dye can be adjusted to adjust the color characteristics of the photoluminescent wavelength conversion film. For example, the weight ratio of the first photoluminescent dye to the second photoluminescent dye may be about 0.01-100 (the ratio of 1 mg of the first photoluminescent dye to 100 mg of the second photoluminescent dye is 0.01), About 0.01-0.2, about 0.2-0.4, about 0.4-0.6, about 0.6-0.8, about 0.8-1, about 1-2, about 2-3, about 3-4, about 4-5, about 5-6, About 6-7, about 7-8, about 8-9, about 9-10, about 10-20, about 20-40, about 40-70, about 70-100, about 0.43, about 0.91, about 1.8 or about 3.0.

在一些實施例中,膜可包含安置於聚合物基質內的散射中心。在一些實施例中,散射中心可為固體顆粒,其包含折射率(RI)不同於聚合物基質材料之折射率的散射材料。散射材料可為折射率不同於聚合物基質之RI的材料。散射材料可用於例如藉由減少全內反射而提高外部量子產率。 材料 RI PMMA 1.49 PVB 1.49 1.42 氣穴或空隙 1.00 In some embodiments, the film may include scattering centers disposed within a polymer matrix. In some embodiments, the scattering centers can be solid particles that contain scattering material with a refractive index (RI) different from that of the polymeric matrix material. The scattering material may be a material with a different refractive index than the RI of the polymer matrix. Scattering materials can be used to increase the external quantum yield, for example by reducing total internal reflection. Material RI PMMA 1.49 PVB 1.49 Silicon 1.42 air pockets or voids 1.00

在一些實施例中,聚合物基質材料與光散射材料之間的RI之差值可為至少0.05、0.1、至少0.2、至少0.3、至少0.4或至少0.5,至多1或2。In some embodiments, the difference in RI between the polymer matrix material and the light scattering material can be at least 0.05, 0.1, at least 0.2, at least 0.3, at least 0.4, or at least 0.5, up to 1 or 2.

在一些實施例中,散射材料可為聚矽氧珠粒。在一些實施例中,散射中心可包含聚合物基質內界定之空隙。在一些實施例中,散射中心之平均直徑可為1微米(µm)至10微米(µm)、約1-2 µm、約2-3 µm、約3-4 µm、約4-5 µm、約5-6 µm、約6-7 µm、約7-8 µm、約8-9 µm、約9-10 µm或約任何此等值所限定之範圍內的任何值。在一些實施例中,散射中心可實質上均勻地分散於聚合物基質內。在一些實施例中,膜之頂層部分(例如遠離藍光發射源之側)可具有大於50%之散射中心。在一些實施例中,散射中心可均勻地分佈於整個聚合物基質中。In some embodiments, the scattering material may be polysilicone beads. In some embodiments, the scattering centers may comprise voids defined within the polymer matrix. In some embodiments, the average diameter of the scattering center may be 1 micron (µm) to 10 microns (µm), about 1-2 µm, about 2-3 µm, about 3-4 µm, about 4-5 µm, about 5-6 µm, about 6-7 µm, about 7-8 µm, about 8-9 µm, about 9-10 µm, or about any value within the range defined by any of these values. In some embodiments, the scattering centers can be substantially uniformly dispersed within the polymer matrix. In some embodiments, the top portion of the film (eg, the side away from the blue light emitting source) may have a scattering center greater than 50%. In some embodiments, the scattering centers can be evenly distributed throughout the polymer matrix.

在一些實施例中,在紅光或綠光發射最大值下,光致發光波長轉換膜可具有至少約70%、至少約80%或至少約90%;及/或至多約80%、至多約90%、至多約100%之內部量子產率(IQE)。在一些實施例中,在紅光或綠光發射最大值下,光致發光波長轉換膜可具有至少約50%、至少約60%、至少約70%、至少約80%或至少約90%;及/或至多約80%、至多約90%或至多約100%之外部量子產率(EQE)。In some embodiments, the photoluminescent wavelength conversion film may have at least about 70%, at least about 80%, or at least about 90% at the red or green light emission maximum; and/or at most about 80%, at most about Internal quantum yield (IQE) of 90%, up to about 100%. In some embodiments, the photoluminescent wavelength conversion film may have at least about 50%, at least about 60%, at least about 70%, at least about 80%, or at least about 90% at a red or green light emission maximum; and/or an external quantum yield (EQE) of up to about 80%, up to about 90%, or up to about 100%.

在一些實施例中,顯示裝置可由裝置10表示。如圖1中所示,裝置10可包含光源12。在一些實施例中,顯示裝置10可包含波長轉換(WLC)膜16。在一些實施例中,WLC膜16可與光源12光學通信,使得能夠提高將所產生光自光源12傳輸至觀看者20的有效性。In some embodiments, a display device may be represented by device 10 . As shown in FIG. 1 , device 10 may include light source 12 . In some embodiments, display device 10 may include a wavelength conversion (WLC) film 16 . In some embodiments, WLC film 16 can be in optical communication with light source 12 such that the effectiveness of transmitting generated light from light source 12 to viewer 20 can be increased.

在一些實施例中,顯示裝置可由圖2示意性地表示。如圖2中所示,諸如裝置10之顯示裝置可包含光源12。在一些實施例中,顯示裝置10可包含背部反射器14。在一些實施例中,顯示裝置10可包含波長轉換(WLC)膜16。在一些實施例中,顯示裝置10可包含遮罩18。在一些實施例中,WLC膜16可與光源12光學通信,使得能夠提高將所產生光自光源12傳輸至觀看者20的有效性。In some embodiments, the display device may be schematically represented by FIG. 2 . As shown in FIG. 2 , a display device such as device 10 may include a light source 12 . In some embodiments, display device 10 may include back reflector 14 . In some embodiments, display device 10 may include a wavelength conversion (WLC) film 16 . In some embodiments, display device 10 may include mask 18 . In some embodiments, WLC film 16 can be in optical communication with light source 12 such that the effectiveness of transmitting generated light from light source 12 to viewer 20 can be increased.

在一些實施例中,顯示裝置可由圖3示意性地表示。如圖3中所示,描述了顯示裝置,該裝置10可包含光源12。在一些實施例中,顯示裝置10可包含背部反射器14。在一些實施例中,顯示裝置10可包含波長轉換(WLC)膜16。在一些實施例中,顯示裝置可包含遮罩18。在一些實施例中,WLC膜16可與光源12光學通信,及/或插入於光源12與觀看者20及/或遮罩18之間,使得能夠提高將所產生光自光源12傳輸至觀看者20的有效性。In some embodiments, the display device may be schematically represented by FIG. 3 . As shown in FIG. 3 , a display device is depicted, which device 10 may include a light source 12 . In some embodiments, display device 10 may include back reflector 14 . In some embodiments, display device 10 may include a wavelength conversion (WLC) film 16 . In some embodiments, the display device may include a mask 18 . In some embodiments, WLC film 16 may be in optical communication with light source 12 and/or interposed between light source 12 and viewer 20 and/or mask 18 such that transmission of generated light from light source 12 to the viewer may be enhanced. 20 effectiveness.

如圖3及圖4中所示,在一些實施例中,顯示裝置10可包含一或多個增亮膜(BEF) 22,例如Vikuiti品牌BEF (3M Minneapolis,MN,USA)。在一些實施例中,顯示裝置10可包含一或多個偏光件及/或增亮膜,例如雙重增亮膜(DBEF) 24,例如DBEF II (3M Minneapolis,MN,USA)。在一些實施例中,一或多個增亮膜之使用可稱為光學膜堆疊。As shown in Figures 3 and 4, in some embodiments, the display device 10 may include one or more brightness enhancing films (BEF) 22, such as Vikuiti brand BEF (3M Minneapolis, MN, USA). In some embodiments, display device 10 may include one or more polarizers and/or brightness enhancement films, such as dual brightness enhancement film (DBEF) 24, such as DBEF II (3M Minneapolis, MN, USA). In some embodiments, the use of one or more brightness enhancing films may be referred to as an optical film stack.

一些實施例包括一種用於製造LED光源之方法。在一些實施例中,方法可包含用有機溶劑及本文所描述之光致發光染料製造未乾燥之波長移位聚合層。在一些實施例中,方法可包括使聚合物及/或單體與有機溶劑混合。在一些實施例中,聚合物及/或單體前驅物可經分散、溶解及/或與溶劑混合。在一些實施例中,溶劑可用於製造材料層。在一些實施例中,溶劑可為非極性溶劑。在一些實施例中,非極性溶劑可包括但不限於二甲苯、環己酮、丙酮、甲苯、甲基乙基酮或其任何組合。在一些實施例中,溶劑可為極性溶劑。在一些實施例中,極性溶劑可包含乙醇、二甲基甲醯胺(DMF)或其組合。在一些實施例中,溶劑可為非極性及極性溶劑之組合。Some embodiments include a method for manufacturing an LED light source. In some embodiments, methods can include making an undried wavelength-shifting polymeric layer using an organic solvent and a photoluminescent dye described herein. In some embodiments, methods may include mixing polymers and/or monomers with organic solvents. In some embodiments, polymer and/or monomer precursors can be dispersed, dissolved, and/or mixed with solvents. In some embodiments, solvents can be used to create layers of materials. In some embodiments, the solvent may be a non-polar solvent. In some embodiments, non-polar solvents may include, but are not limited to, xylene, cyclohexanone, acetone, toluene, methyl ethyl ketone, or any combination thereof. In some embodiments, the solvent may be a polar solvent. In some embodiments, the polar solvent may include ethanol, dimethylformamide (DMF), or combinations thereof. In some embodiments, the solvent can be a combination of non-polar and polar solvents.

在一些實施例中,方法可包含將未乾燥之聚合光催化WLC層浸沒在水溶液中。在一些實施例中,水溶液可包含水。在一些實施例中,水溶液可包含至少90%水。在一些實施例中,水可為去離子水。在一些實施例中,未乾燥之聚合光催化WLC層可浸沒在水溶液中5分鐘至約1小時。In some embodiments, the method may include immersing the undried polymeric photocatalytic WLC layer in an aqueous solution. In some embodiments, the aqueous solution may include water. In some embodiments, the aqueous solution may contain at least 90% water. In some embodiments, the water can be deionized water. In some embodiments, the undried polymeric photocatalytic WLC layer can be immersed in the aqueous solution for 5 minutes to about 1 hour.

在一些實施例中,方法可包含自水溶液取出未乾燥之聚合光催化WLC層。在一些實施例中,方法可包含使未乾燥之聚合光催化WLC層乾燥。咸信以此方式製造聚合光催化WLC層提供複數個界定於聚合光催化WLC層之發射表面或遠端表面中之空隙。在一些實施例中,空隙基本上完全在距聚合光催化WLC層之發射表面約1微米至約5微米內。In some embodiments, the method may include removing the undried polymerized photocatalytic WLC layer from the aqueous solution. In some embodiments, the method may include drying the undried polymerized photocatalytic WLC layer. It is believed that fabricating the polymeric photocatalytic WLC layer in this manner provides a plurality of voids defined in the emissive or distal surface of the polymeric photocatalytic WLC layer. In some embodiments, the voids are substantially entirely within about 1 micron to about 5 microns of the emissive surface of the polymeric photocatalytic WLC layer.

在一些實施例中,聚合材料包含約2 wt%至約50 wt%聚合物、約2-5 wt%、約5-10 wt%、約10-15 wt%、約15-20 wt%、約20-25 wt%、約25-30 wt%、約30-35 wt%、約35-40 wt%、約40-45 wt%、約45-50 wt%、約2.5 to 30 wt%、約5-15 wt%、約15-25 wt%、約25-35 wt%或約30 wt%聚合物,或約任何此等值所限定之範圍內之任何值之聚合物的水溶液。 實施例 實施例1.一種波長轉換膜,其包含: 聚合物基質; 第一光致發光染料,該第一光致發光染料吸收藍色波長光且以半高寬小於30 nm之發射光譜嚴密地發射綠色波長光; 第二光致發光染料,該第二光致發光染料吸收藍色或綠色波長光且以半高寬小於55 nm之發射光譜嚴密地發射紅色波長光;及 光散射中心, 其中該第一光致發光染料、該第二光致發光染料及該光散射中心安置於該聚合物基質內。 實施例2.如實施例1之波長轉換膜,其中該第一光致發光染料包含BODIPY基團、連接基團及異喹啉基。 實施例3.如實施例2之波長轉換膜,其中該第一光致發光染料係選自: (FD-1),或 (FD-3)。 實施例4.如實施例1之波長轉換膜,其中該第一光致發光染料包含BODIPY基團、連接基團及萘二甲酸醯亞胺基。 實施例5.如實施例4之波長轉換膜,其中該第一光致發光染料係選自: (FD-2)。 實施例6.如實施例1之波長轉換膜,其中該第二光致發光染料包含BODIPY基團、連接基團及異喹啉基。 實施例7.如實施例6之波長轉換膜,其中該第二光致發光染料係選自: (SD-1), (SD-2),或 (SD-4)。 實施例8.如實施例1之波長轉換膜,其中該第二光致發光染料包含BODIPY基團、連接基團及萘二甲醯亞胺基。 實施例9.如實施例8之波長轉換膜,其中該第二光致發光染料係選自: 實施例10.如實施例1之波長轉換膜,其中該第二光致發光染料包含BODIPY基團、連接基團及苝基。 實施例11.如實施例8之波長轉換膜,其中該第二光致發光染料係選自: (SD-3)。 實施例12.如實施例1至11之波長轉換膜,其中該波長轉換膜具有大於80%之內部量子產率。 實施例13.如實施例1至11之波長轉換膜,其中該波長轉換膜具有大於50%之外部量子產率。 實施例14.如實施例1至11之波長轉換膜,其中該波長轉換膜具有大於BT.2020標準之90%的色域。 實施例15.如實施例1至11之波長轉換膜,其中該波長轉換膜具有10 µm與40 µm之間的厚度。 實施例16.一種發光裝置,其包含如實施例1至15之波長轉換膜。 實施例17.一種具有藍色光源之背光裝置,該裝置包含實施例1至15之波長轉換薄膜。 實例 In some embodiments, the polymeric material includes about 2 wt% to about 50 wt% polymer, about 2-5 wt%, about 5-10 wt%, about 10-15 wt%, about 15-20 wt%, about 20-25 wt%, about 25-30 wt%, about 30-35 wt%, about 35-40 wt%, about 40-45 wt%, about 45-50 wt%, about 2.5 to 30 wt%, about 5 - an aqueous solution of 15 wt%, about 15-25 wt%, about 25-35 wt%, or about 30 wt% polymer, or about any value within the range defined by these values. Examples Example 1. A wavelength conversion film, comprising: a polymer matrix; a first photoluminescent dye that absorbs blue wavelength light and has an emission spectrum with a half-maximum width less than 30 nm. Emitting green wavelength light; a second photoluminescent dye that absorbs blue or green wavelength light and strictly emits red wavelength light with an emission spectrum with a half-maximum width less than 55 nm; and a light scattering center, wherein The first photoluminescent dye, the second photoluminescent dye and the light scattering center are disposed within the polymer matrix. Embodiment 2. The wavelength conversion film of Embodiment 1, wherein the first photoluminescent dye includes a BODIPY group, a linking group and an isoquinolinyl group. Embodiment 3. The wavelength conversion film of Embodiment 2, wherein the first photoluminescent dye is selected from: (FD-1), or (FD-3). Embodiment 4. The wavelength conversion film of Embodiment 1, wherein the first photoluminescent dye includes a BODIPY group, a linking group and a naphthalenedicarboxylic acid imide group. Embodiment 5. The wavelength conversion film of Embodiment 4, wherein the first photoluminescent dye is selected from: (FD-2). Embodiment 6. The wavelength conversion film of Embodiment 1, wherein the second photoluminescent dye includes a BODIPY group, a linking group and an isoquinolinyl group. Embodiment 7. The wavelength conversion film of Embodiment 6, wherein the second photoluminescent dye is selected from: (SD-1), (SD-2), or (SD-4). Embodiment 8. The wavelength conversion film of Embodiment 1, wherein the second photoluminescent dye includes a BODIPY group, a linking group and a naphthalenedimide group. Embodiment 9. The wavelength conversion film of Embodiment 8, wherein the second photoluminescent dye is selected from: . Embodiment 10. The wavelength conversion film of Embodiment 1, wherein the second photoluminescent dye includes a BODIPY group, a linking group and a perylene group. Embodiment 11. The wavelength conversion film of Embodiment 8, wherein the second photoluminescent dye is selected from: (SD-3). Embodiment 12. The wavelength conversion film of embodiments 1 to 11, wherein the wavelength conversion film has an internal quantum yield greater than 80%. Embodiment 13. The wavelength conversion film of embodiments 1 to 11, wherein the wavelength conversion film has an external quantum yield greater than 50%. Embodiment 14. The wavelength conversion film of embodiments 1 to 11, wherein the wavelength conversion film has a color gamut greater than 90% of the BT.2020 standard. Embodiment 15. The wavelength conversion film of embodiments 1 to 11, wherein the wavelength conversion film has a thickness between 10 µm and 40 µm. Embodiment 16. A light-emitting device comprising the wavelength conversion film of embodiments 1 to 15. Embodiment 17. A backlight device with a blue light source, the device includes the wavelength conversion film of Embodiments 1 to 15. Example

已發現包括本文所描述之光致發光錯合物之膜之實施例具有相較於其他形式之色彩轉換膜有所改良之效能。此等益處由以下實例進一步證實,該等實例意欲說明本發明,但並不意欲以任何方式限制範疇或基礎原理。 合成第一光致發光染料 化合物 FD-1 合成程序 化合物 FD-1.1 Embodiments of films including the photoluminescent complexes described herein have been found to have improved performance compared to other forms of color conversion films. These benefits are further demonstrated by the following examples, which are intended to illustrate the invention but are not intended to limit the scope or underlying principles in any way. Synthetic procedure for synthesizing the first photoluminescent dye compound FD-1 Compound FD-1.1 :

使2,4-二甲基-1H-吡咯-3-甲酸乙酯(1.0 g,6.0 mmol)、4-羥基-2,6-二甲基苯甲醛(0.449 g,3.0 mmol)及對甲苯磺酸(50 mg,0.29 mmol)於50 mL 1,2-二氯乙烷中之混合物脫氣且在室溫下攪拌過夜。LCMS分析顯示一個主峰,其中m/e+ = 467。Make 2,4-dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester (1.0 g, 6.0 mmol), 4-hydroxy-2,6-dimethylbenzaldehyde (0.449 g, 3.0 mmol) and p-toluenesulfonate. A mixture of acid (50 mg, 0.29 mmol) in 50 mL 1,2-dichloroethane was degassed and stirred at room temperature overnight. LCMS analysis showed one main peak with m/e+ = 467.

向所得溶液中添加DDQ (0.817 g,3.6 mmol),隨後在室溫下攪拌30 min。LCMS分析顯示所有起始物質轉換為所需產物,其中m/e+ =465。DDQ (0.817 g, 3.6 mmol) was added to the resulting solution, followed by stirring at room temperature for 30 min. LCMS analysis showed conversion of all starting material to the desired product with m/e+ =465.

在冰浴冷卻下,將1.7 mL三乙胺及2.2 mL BF3-乙醚依序添加至來自步驟2之混合物中。全部在50℃下加熱一小時。LCMS分析顯示約30%轉換率。向混合物中再添加1 mL三乙胺及1 mL BF3-乙醚,全部在50℃下再加熱一小時。LCMS分析顯示所有所述材料轉換為所需BODIPY產物,其中m/e+ = 513,m/e- = 512。將反應混合物直接呈遞至矽膠且藉由急驟層析使用溶離劑己烷/乙酸乙酯(0%à30%乙酸乙酯)純化。收集主要所需峰,且移除溶劑得到橙色固體(1.0 g,65%產率)。LCMS (APCI):C27H32BF2N2O5之計算值(M+H):513.2;實驗值:513。1H NMR (400 MHz, 氯仿-d) δ 7.26 (s, 3H), 6.68 (s, 2H), 4.29 (q, J = 7.1 Hz, 4H), 2.84 (s, 6H), 2.05 (s, 6H), 1.34 (t, J = 7.1 Hz, 6H)。 化合物 FD-1.2 Under ice bath cooling, 1.7 mL triethylamine and 2.2 mL BF3-ethyl ether were added sequentially to the mixture from step 2. All heated at 50°C for one hour. LCMS analysis showed approximately 30% conversion. Add another 1 mL of triethylamine and 1 mL of BF3-ethyl ether to the mixture, and heat all at 50°C for another hour. LCMS analysis showed conversion of all of the material to the desired BODIPY product with m/e+ = 513 and m/e- = 512. The reaction mixture was presented directly to silica gel and purified by flash chromatography using the eluant hexane/ethyl acetate (0% to 30% ethyl acetate). The main desired peak was collected and the solvent was removed to give an orange solid (1.0 g, 65% yield). LCMS (APCI): Calculated for C27H32BF2N2O5 (M+H): 513.2; found: 513. 1H NMR (400 MHz, chloroform-d) δ 7.26 (s, 3H), 6.68 (s, 2H), 4.29 (q , J = 7.1 Hz, 4H), 2.84 (s, 6H), 2.05 (s, 6H), 1.34 (t, J = 7.1 Hz, 6H). Compound FD-1.2 :

將2-硝基苯酚(6.6 g,48 mmol)、KOH粉末(2.4 g,43 mmol)混合且真空攪拌30 min,隨後添加銅粉(0.4 g),之後添加100 mL無水DMF。攪拌混合物5 min,隨後添加4-氯萘二甲酸酐(5.1 g,22 mmol)。全部脫氣,隨後加熱回流1.5 hr。冷卻至室溫後,將100 mL 20%鹽酸逐滴添加至所得反應混合物中,將其靜置2 hr。藉由過濾收集沈澱物,隨後真空乾燥過夜,得到黃棕色固體(4.6 g)。藉由於回流乙酸(50 mL)中攪拌2 hr,隨後冷卻至室溫而進一步純化。過濾且於空氣中乾燥,得到黃色固體(3.0 g,41%產率)。藉由LCMS (APCI)確認:C18H10NO6之計算值(M+H):336.0;實驗值:336。 1H NMR (400 MHz, 氯仿-d) δ 8.80 (dd, J = 8.5, 1.2 Hz, 1H), 8.72 (dd, J = 7.3, 1.2 Hz, 1H), 8.50 (d, J = 8.2 Hz, 1H), 8.19 (dd, J = 8.2, 1.7 Hz, 1H), 7.90 (dd, J = 8.5, 7.3 Hz, 1H), 7.79 (td, J = 7.9, 1.7 Hz, 1H), 7.54 (td, J = 8.0, 1.3 Hz, 1H), 7.39 (dd, J = 8.3, 1.2 Hz, 1H), 6.89 (d, J = 8.2 Hz, 1H)。 化合物 FD-1.3 2-Nitrophenol (6.6 g, 48 mmol), KOH powder (2.4 g, 43 mmol) were mixed and stirred under vacuum for 30 min, then copper powder (0.4 g) was added, followed by 100 mL of anhydrous DMF. The mixture was stirred for 5 min, then 4-chloronaphthalic anhydride (5.1 g, 22 mmol) was added. All were degassed and then heated to reflux for 1.5 hr. After cooling to room temperature, 100 mL of 20% hydrochloric acid was added dropwise to the resulting reaction mixture and allowed to stand for 2 hr. The precipitate was collected by filtration and then dried under vacuum overnight to give a yellow-brown solid (4.6 g). Further purification was performed by stirring in refluxing acetic acid (50 mL) for 2 hr, followed by cooling to room temperature. Filtration and drying in air gave a yellow solid (3.0 g, 41% yield). Confirmed by LCMS (APCI): Calculated value (M+H) of C18H10NO6: 336.0; Experimental value: 336. 1 H NMR (400 MHz, chloroform-d) δ 8.80 (dd, J = 8.5, 1.2 Hz, 1H), 8.72 (dd, J = 7.3, 1.2 Hz, 1H), 8.50 (d, J = 8.2 Hz, 1H ), 8.19 (dd, J = 8.2, 1.7 Hz, 1H), 7.90 (dd, J = 8.5, 7.3 Hz, 1H), 7.79 (td, J = 7.9, 1.7 Hz, 1H), 7.54 (td, J = 8.0, 1.3 Hz, 1H), 7.39 (dd, J = 8.3, 1.2 Hz, 1H), 6.89 (d, J = 8.2 Hz, 1H). Compound FD-1.3 :

將化合物 FD- 1.24-(2-硝基苯氧基)-1,8-萘二甲酸酐(2.0 g,6 mmol)及鐵粉(<10 um,0.91 g,16 mmol)於乙酸(75 mL)中之混合物加熱至回流30 min。將所得溶液倒入水(220 mL)中。藉由過濾收集所得沈澱物且用水洗滌,病在空氣中隨後真空下徹底乾燥,得到黃色固體(1.65 g,90%產率)。藉由LCMS (APCI)確認:C 18H 12NO 4之計算值(M+H):306.1;實驗值:306。 化合物 FD-1.4 Compound FD - 1.2 4-(2-nitrophenoxy)-1,8-naphthalenedicarboxylic anhydride (2.0 g, 6 mmol) and iron powder (<10 um, 0.91 g, 16 mmol) were dissolved in acetic acid (75 mL) and heated to reflux for 30 min. The resulting solution was poured into water (220 mL). The resulting precipitate was collected by filtration and washed with water, dried thoroughly in air and then under vacuum to give a yellow solid (1.65 g, 90% yield). Confirmed by LCMS (APCI): Calculated for C 18 H 12 NO 4 (M+H): 306.1; Found: 306. Compound FD-1.4 :

將化合物 FD-1.34-(2-胺基苯氧基)-1,8-萘二甲酸酐(1.5 g,4.9 mmol)分散於乙酸(35 mL)中且冷卻至0℃。在攪拌之同時,添加預冷卻之鹽酸(3 mL,37 mmol),隨後在0℃下逐滴添加亞硝酸鈉(3.29 g,46 mmol)於12 mL水中之溶液。全部在0℃下攪拌一小時,隨後轉移至另一漏斗中,且經一小時時段滴入回流硫酸銅溶液(5.08 g,20 mmol,於50 mL水中)中。冷卻至室溫後,藉由過濾收集沈澱物,用水洗滌,隨後在空氣中乾燥,隨後真空中乾燥,得到黃色固體(0.92 g,65%產率)。藉由LCMS (APCI)確認:C 18H 8O 4之計算值(M-):288.0;實驗值:288。 1H NMR (400 MHz, 氯仿-d) δ 8.61 (dd, J = 17.1, 8.1 Hz, 2H), 8.09 (d, J = 8.0 Hz, 1H), 7.97 (d, J = 7.9 Hz, 1H), 7.59 (t, J = 7.7 Hz, 1H), 7.40 (t, J = 8.1 Hz, 2H), 7.33 (d, J = 8.4 Hz, 1H)。 化合物 FD-1.5 Compound FD-1.3 4-(2-aminophenoxy)-1,8-naphthalenedicarboxylic anhydride (1.5 g, 4.9 mmol) was dispersed in acetic acid (35 mL) and cooled to 0°C. While stirring, precooled hydrochloric acid (3 mL, 37 mmol) was added, followed by a solution of sodium nitrite (3.29 g, 46 mmol) in 12 mL of water dropwise at 0°C. All was stirred at 0°C for one hour, then transferred to another funnel and dropped into refluxing copper sulfate solution (5.08 g, 20 mmol in 50 mL water) over a period of one hour. After cooling to room temperature, the precipitate was collected by filtration, washed with water, and then dried in air and then in vacuo to give a yellow solid (0.92 g, 65% yield). Confirmed by LCMS (APCI): Calculated for C 18 H 8 O 4 (M-): 288.0; Found: 288. 1 H NMR (400 MHz, chloroform-d) δ 8.61 (dd, J = 17.1, 8.1 Hz, 2H), 8.09 (d, J = 8.0 Hz, 1H), 7.97 (d, J = 7.9 Hz, 1H), 7.59 (t, J = 7.7 Hz, 1H), 7.40 (t, J = 8.1 Hz, 2H), 7.33 (d, J = 8.4 Hz, 1H). Compound FD-1.5 :

在微波反應器中在165℃下加熱化合物 FD-1.41H,3H-異苯并哌喃并[6,5,4-mna]𠮿-1,3-二酮(100 mg,0.347 mmol)、4-(4-胺基苯基)丁酸(125 mg,0.7 mmol)於5 mL DMF中之混合物2.5 hr。向混合物中添加15 mL丙酮,藉由過濾收集所得沈澱物且於空氣中乾燥,得到黃色固體(120 mg,77%產率)。藉由LCMS (APCI)確認:C 28H 19NO 5之計算值(M-):449.1;實驗值:449。 1H NMR (400 MHz, DMSO-d6) δ 8.38 (d, J = 41.6 Hz, 4H), 7.81 - 6.97 (m, 8H), 2.69 - 2.64 (m, 2H), 2.26 (t, J = 7.2 Hz, 2H), 1.87 (p, J = 7.2 Hz, 2H)。 化合物 FD-1 Heating compound FD-1.4 1H,3H-isobenzopirano[6,5,4-mna]𠮿 in a microwave reactor at 165°C -A mixture of 1,3-dione (100 mg, 0.347 mmol), 4-(4-aminophenyl)butyric acid (125 mg, 0.7 mmol) in 5 mL DMF for 2.5 hr. 15 mL of acetone was added to the mixture, and the resulting precipitate was collected by filtration and dried in air to obtain a yellow solid (120 mg, 77% yield). Confirmed by LCMS (APCI): Calculated for C 28 H 19 NO 5 (M-): 449.1; Found: 449. 1 H NMR (400 MHz, DMSO-d6) δ 8.38 (d, J = 41.6 Hz, 4H), 7.81 - 6.97 (m, 8H), 2.69 - 2.64 (m, 2H), 2.26 (t, J = 7.2 Hz , 2H), 1.87 (p, J = 7.2 Hz, 2H). Compound FD-1 :

在室溫下攪拌化合物 FD-1.5(45 mg,0.1 mmol)、化合物 FD-1.1(40 mg,0.078 mmol)、DMAP/TsOH鹽(59 mg,0.2 mmol)及DIC (0.1 mL,0.63 mmol)於5 mL DCM中之混合物過夜,隨後在45℃下攪拌2 hr。將反應混合物呈遞至矽膠且藉由急驟層析使用溶離劑DCM/乙酸乙酯(0%至10%乙酸乙酯)純化。收集所需產物峰且減壓濃縮。所得固體用甲醇進一步洗滌且在空氣中乾燥,得到橙色固體(46 mg,62%產率)。藉由LCMS (APCI)確認:C 55H 49BF 2N 3O 9之計算值(M+H):944.3;實驗值:944。 1H NMR (400 MHz, d2-TCE) δ 8.54 (dd, J = 18.7, 8.1 Hz, 2H), 7.40 - 7.25 (m, 5H), 7.20 (d, J = 8.3 Hz, 2H), 6.93 (s, 2H), 4.19 (q, J = 7.1 Hz, 4H), 2.80 (t, J = 7.6 Hz, 2H), 2.75 (s, 6H), 2.62 (t, J = 7.4 Hz, 2H), 2.10 (t, J = 7.6 Hz, 2H), 2.06 (s, 6H), 1.65 (s, 6H), 1.25 (t, J = 7.1 Hz, 6H)。 化合物 FD-2 之合成程序 化合物 FD-2.1 Compound FD-1.5 (45 mg, 0.1 mmol), compound FD-1.1 (40 mg, 0.078 mmol), DMAP/TsOH salt (59 mg, 0.2 mmol) and DIC (0.1 mL, 0.63 mmol) were stirred at room temperature. The mixture in 5 mL DCM was incubated overnight and then stirred at 45°C for 2 hr. The reaction mixture was submitted to silica gel and purified by flash chromatography using the eluant DCM/ethyl acetate (0% to 10% ethyl acetate). The desired product peak was collected and concentrated under reduced pressure. The resulting solid was further washed with methanol and dried in air to give an orange solid (46 mg, 62% yield). Confirmed by LCMS (APCI): Calculated for C 55 H 49 BF 2 N 3 O 9 (M+H): 944.3; Found: 944. 1 H NMR (400 MHz, d2-TCE) δ 8.54 (dd, J = 18.7, 8.1 Hz, 2H), 7.40 - 7.25 (m, 5H), 7.20 (d, J = 8.3 Hz, 2H), 6.93 (s , 2H), 4.19 (q, J = 7.1 Hz, 4H), 2.80 (t, J = 7.6 Hz, 2H), 2.75 (s, 6H), 2.62 (t, J = 7.4 Hz, 2H), 2.10 (t , J = 7.6 Hz, 2H), 2.06 (s, 6H), 1.65 (s, 6H), 1.25 (t, J = 7.1 Hz, 6H). Synthetic procedure of compound FD-2 Compound FD-2.1 :

使2,4-二甲基-1H-吡咯-3-甲酸乙酯(1.0 g,6.0 mmol)、4-羥基-2,6-二甲基苯甲醛(0.449 g,3.0 mmol)及對甲苯磺酸(p-TsOH)(50 mg,0.29 mmol)於50 mL二氯乙烷(DCE)中之混合物脫氣且在室溫下攪拌過夜。液相層析質譜(LCMS)分析顯示反應完成,其中主峰之m/e += 467。向上文獲得之混合物中添加2,3-二氯-5,6-二氰基-1,4-苯醌(DDQ)(0.817 g,3.6 mmol)且全部在室溫下攪拌30 min。LCMS分析指示反應完成,其中主峰之m/e += 465。在冰浴冷卻下,向上文獲得之混合物中添加三乙胺(1.7 mL,12 mmol)及BF 3-乙醚(2.2 mL,18 mmol),且在50℃下攪拌所得混合物一小時。再添加1 mL三乙胺及1 mL BF 3-乙醚,且全部再加熱一小時。LCMS分析指示所有二吡咯次甲基起始物質轉換為BODIPY產物,其中m/e += 513。冷卻至室溫後,將反應混合物呈遞至矽膠且藉由急驟層析使用溶離劑己烷/乙酸乙酯(0%至30%乙酸乙酯)純化。收集所需溶離份。移除溶劑後,獲得呈橙色固體之所需產物(1.0 g,65%產率)。 1H NMR (400 MHz, 氯仿-d) δ 6.68 (s, 2H), 4.29 (q, J = 7.1 Hz, 4H), 2.84 (s, 6H), 2.05 (s, 6H), 1.34 (t, J = 7.1 Hz, 6H)。LCMS (APCI+):C 27H 32BF 2N 2O 5之計算值(M+H) = 513.2;實驗值:513。 化合物 FD-2 Make 2,4-dimethyl-1H-pyrrole-3-carboxylic acid ethyl ester (1.0 g, 6.0 mmol), 4-hydroxy-2,6-dimethylbenzaldehyde (0.449 g, 3.0 mmol) and p-toluenesulfonate. A mixture of acid (p-TsOH) (50 mg, 0.29 mmol) in 50 mL dichloroethane (DCE) was degassed and stirred at room temperature overnight. Liquid chromatography mass spectrometry (LCMS) analysis showed that the reaction was complete, with the main peak having m/e + = 467. To the mixture obtained above was added 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) (0.817 g, 3.6 mmol) and the whole was stirred at room temperature for 30 min. LCMS analysis indicated completion of the reaction with the main peak having m/e + = 465. Under ice bath cooling, triethylamine (1.7 mL, 12 mmol) and BF 3 -ethyl ether (2.2 mL, 18 mmol) were added to the mixture obtained above, and the resulting mixture was stirred at 50°C for one hour. An additional 1 mL of triethylamine and 1 mL of BF 3 -ethyl ether were added and all heated for another hour. LCMS analysis indicated conversion of all dipyrromethine starting material to the BODIPY product with m/e + = 513. After cooling to room temperature, the reaction mixture was transferred to silica gel and purified by flash chromatography using the eluant hexane/ethyl acetate (0% to 30% ethyl acetate). Collect the required fractions. After removal of the solvent, the desired product was obtained as an orange solid (1.0 g, 65% yield). 1 H NMR (400 MHz, chloroform-d) δ 6.68 (s, 2H), 4.29 (q, J = 7.1 Hz, 4H), 2.84 (s, 6H), 2.05 (s, 6H), 1.34 (t, J = 7.1 Hz, 6H). LCMS (APCI+): Calculated for C 27 H 32 BF 2 N 2 O 5 (M+H) = 513.2; found: 513. Compound FD-2 :

在室溫下攪拌化合物FD-2.1 (100 mg,0.195 mmol)、FD-2.2 (4-(4-(6-(4-(二苯胺基)苯基)-1,3-二側氧基-1H-苯并[de]異喹啉-2(3H)-基)苯基)丁酸)(132 mg,0.22 mmol)、二異丙基碳化二亞胺(DIC)(0.1 mL,0.63 mmol)及二甲胺基吡啶(DMAP)/p-TsOH (118 mg,0.4 mmol)於二氯甲烷(DCM)(6 mL)中之混合物過夜,隨後裝載於矽膠上,且藉由急驟層析使用溶離劑DCM/乙酸乙酯(0%至5%乙酸乙酯)純化。收集所需主要橙色溶離份。移除溶劑後,所得固體於DCM/MeOH中再沈澱。在過濾及在空氣中乾燥之後獲得呈橙色固體之所需產物(145 mg,68%產率)。 1H NMR (400 MHz, d2-TCE) δ 8.56 (dd, J = 7.4, 4.7 Hz, 2H), 8.43 (d, J = 8.3 Hz, 1H), 7.79 - 7.64 (m, 2H), 7.41 - 7.18 (m, 10H), 7.18 - 7.12 (m, 6H), 7.03 (t, J = 7.3 Hz, 2H), 6.93 (s, 2H), 4.19 (q, J = 7.1 Hz, 4H), 2.81 (t, J = 7.6 Hz, 2H), 2.75 (s, 6H), 2.62 (t, J = 7.4 Hz, 2H), 2.11 (t, J = 7.5 Hz, 2H), 2.06 (s, 6H), 1.65 (s, 6H), 1.25 (t, J = 7.1 Hz, 6H)。LCMS (APCI-):C 67H 59BF 2N 4O 8之計算值(M-) = 1096.4;實驗值:1096。 化合物 FD-3 之合成程序 FD-3.1 合成之程序 —2-(4-(9- -1,3- 二側氧基 -1H- 𠮿 [2,1,9-def] 異喹啉 -2(3H)- ) 苯基 ) 乙酸 Compounds FD-2.1 (100 mg, 0.195 mmol), FD-2.2 (4-(4-(6-(4-(diphenylamine)phenyl))-1,3-dilateral oxy- 1H-benzo[de]isoquinolin-2(3H)-yl)phenyl)butyric acid) (132 mg, 0.22 mmol), diisopropylcarbodiimide (DIC) (0.1 mL, 0.63 mmol) and a mixture of dimethylaminopyridine (DMAP)/p-TsOH (118 mg, 0.4 mmol) in dichloromethane (DCM) (6 mL) overnight, then loaded on silica and eluted by flash chromatography. Purify using DCM/ethyl acetate (0% to 5% ethyl acetate). Collect the desired major orange fraction. After removal of the solvent, the solid obtained was reprecipitated in DCM/MeOH. After filtration and drying in air the desired product was obtained as an orange solid (145 mg, 68% yield). 1 H NMR (400 MHz, d2-TCE) δ 8.56 (dd, J = 7.4, 4.7 Hz, 2H), 8.43 (d, J = 8.3 Hz, 1H), 7.79 - 7.64 (m, 2H), 7.41 - 7.18 (m, 10H), 7.18 - 7.12 (m, 6H), 7.03 (t, J = 7.3 Hz, 2H), 6.93 (s, 2H), 4.19 (q, J = 7.1 Hz, 4H), 2.81 (t, J = 7.6 Hz, 2H), 2.75 (s, 6H), 2.62 (t, J = 7.4 Hz, 2H), 2.11 (t, J = 7.5 Hz, 2H), 2.06 (s, 6H), 1.65 (s, 6H), 1.25 (t, J = 7.1 Hz, 6H). LCMS (APCI-): Calculated for C 67 H 59 BF 2 N 4 O 8 (M-) = 1096.4; found: 1096. Synthetic procedure of compound FD-3 Synthesis procedure of FD-3.1 - 2-(4-(9- bromo -1,3- bilateral oxygen -1H- 𠮿 And [2,1,9-def] isoquinolin -2(3H) -yl ) phenyl ) acetic acid :

在室溫下使 SD-2.6(400.0 mg,1.1 mmol)、4-胺基苯基乙酸(329.4 mg,2.2 mmol)及DMAP (9.3 mg,0.080 mmol)於DMF (8 mL)中之混合物脫氣。隨後將混合物加熱至165℃且保持於此溫度下3 hr。TLC及LCMS顯示約95%轉換率,無可觀測副反應。將混合物冷卻至50℃。隨後將其倒入已藉由水-冰浴預先冷卻之丙酮溶液(40 mL)中。將混合物保持在0℃下2 hr且在室溫下保持攪拌過夜。經由真空過濾收集固體且藉由丙酮(4 mL)洗滌。且藉由真空烘箱在100℃下乾燥3 hr,得到呈黃棕色固體之純化合物 FD-3.1(395.0 mg,73%產率)。MS (APCI):C 26H 14BrNO 5之計算值([M+H]+) =500 實驗值:500。 1H NMR (400 MHz, CDCl 2CDCl 2) δ 8.65 (d, J = 8.0 Hz, 1H), 8.62 (d, J = 8.0 Hz, 1H), 8.21 (dd, J = 6.4 Hz, 2.4 Hz, 1H), 7.99 (bs, 1H), 7.95 (t, J = 7.6 Hz, 1H), 7.67 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 7.53 (d, J = 8.0 Hz, 2H), 7.37 (d, J = 8.4 Hz, 1H), 7.32 (m, 3H), 2.94 (s, 2H)。 化合物 SD-5.1 合成之程序 -2-(4-(1,3- 二側氧基 -9-(4-( 三氟甲基 ) 苯基 )-1H- 𠮿 [2,1,9-def] 異喹啉 -2(3H)- ) 苯基 ) 乙酸 Degas a mixture of SD-2.6 (400.0 mg, 1.1 mmol), 4-aminophenylacetic acid (329.4 mg, 2.2 mmol) and DMAP (9.3 mg, 0.080 mmol) in DMF (8 mL) at room temperature. . The mixture was then heated to 165°C and maintained at this temperature for 3 hr. TLC and LCMS showed about 95% conversion rate and no observable side reactions. The mixture was cooled to 50°C. This was then poured into an acetone solution (40 mL) that had been pre-cooled by a water-ice bath. The mixture was kept at 0°C for 2 hr and kept stirring at room temperature overnight. The solid was collected via vacuum filtration and washed with acetone (4 mL). And by drying in a vacuum oven at 100°C for 3 hr, pure compound FD-3.1 (395.0 mg, 73% yield) was obtained as a yellow-brown solid. MS (APCI): Calculated value of C 26 H 14 BrNO 5 ([M+H]+) =500 Experimental value: 500. 1 H NMR (400 MHz, CDCl 2 CDCl 2 ) δ 8.65 (d, J = 8.0 Hz, 1H), 8.62 (d, J = 8.0 Hz, 1H), 8.21 (dd, J = 6.4 Hz, 2.4 Hz, 1H ), 7.99 (bs, 1H), 7.95 (t, J = 7.6 Hz, 1H), 7.67 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 7.53 (d, J = 8.0 Hz, 2H), 7.37 ( d, J = 8.4 Hz, 1H), 7.32 (m, 3H), 2.94 (s, 2H). Synthesis procedure of compound SD-5.1-2- (4-(1,3- dilateral oxygen -9-(4-( trifluoromethyl ) phenyl )-1H- 𠮿 And [2,1,9-def] isoquinolin -2(3H) -yl ) phenyl ) acetic acid :

100 mL小瓶裝配有攪拌棒。在小瓶中,在室溫下使含化合物 FD-3.1(400.0 mg,0.80 mmol)、4-(三氟甲基)苯基硼酸(4-(trifluoromethyl)phenylboronic acid)(262.2 mg,1.6 mmol)、Pd(dppf)Cl 2(41.0 mg,0.056 mmol)及K 2CO 3(298.0 mg,2.2 mmol)之THF/DMF/H 2O (22 ml/4.4 ml/2.2 ml)脫氣。將反應混合物加熱至80℃且將反應物保持在此溫度下過夜。使用TLC監測反應。完成後,藉由添加0.1 N HCl (150 ml)及EtOAc (150 ml)處理反應物。藉由THF (150 ml×3)進一步萃取水相。合併之有機相經無水Na 2SO 4乾燥,在旋轉蒸發儀下濃縮且藉由急驟層析使用DCM/EtOAc (0-40%,含0.1% TFA)作為溶離劑來純化,得到呈黃色/黃棕色固體之純RL-萘二甲醯亞胺衍生物 SD-5.1。363.0 mg,80%產率。MS (APCI):C 33H 18F 3NO 5之計算值([M+H]+) = 566 實驗值:566。 1H NMR (400 MHz, DMSO-d6) 8.76 (m, 1H), 8.56 (m, 2H), 8.52 (dd, J = 8.0 Hz, J = 3.2 Hz, 1H), 8.15 (m, 2H), 8.06 (m, 1H), 7.94 (d, J = 8.0 Hz, 2H), 7.66 (dd, J = 8.0 Hz, J = 4.0 Hz, 1H), 7.53 (m, 1H), 7.45 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 3.72 (s, 2H)。 化合物 FD-3 之程序: The 100 mL vial is equipped with a stir bar. In a vial, mix compound FD-3.1 (400.0 mg, 0.80 mmol), 4-(trifluoromethyl)phenylboronic acid (262.2 mg, 1.6 mmol), Degas Pd(dppf)Cl 2 (41.0 mg, 0.056 mmol) and K 2 CO 3 (298.0 mg, 2.2 mmol) in THF/DMF/H 2 O (22 ml/4.4 ml/2.2 ml). The reaction mixture was heated to 80°C and the reaction was maintained at this temperature overnight. The reaction was monitored using TLC. Upon completion, the reaction was treated by adding 0.1 N HCl (150 ml) and EtOAc (150 ml). The aqueous phase was further extracted with THF (150 ml×3). The combined organic phases were dried over anhydrous Na 2 SO 4 , concentrated on a rotary evaporator and purified by flash chromatography using DCM/EtOAc (0-40% with 0.1% TFA) as eluent to give a yellow/yellow color Pure RL-naphthalenedimine derivative SD-5.1 is a brown solid. 363.0 mg, 80% yield. MS (APCI): Calculated value for C 33 H 18 F 3 NO 5 ([M+H]+) = 566 Experimental value: 566. 1 H NMR (400 MHz, DMSO-d6) 8.76 (m, 1H), 8.56 (m, 2H), 8.52 (dd, J = 8.0 Hz, J = 3.2 Hz, 1H), 8.15 (m, 2H), 8.06 (m, 1H), 7.94 (d, J = 8.0 Hz, 2H), 7.66 (dd, J = 8.0 Hz, J = 4.0 Hz, 1H), 7.53 (m, 1H), 7.45 (d, J = 8.0 Hz , 2H), 7.33 (d, J = 8.0 Hz, 2H), 3.72 (s, 2H). Procedure for compound FD-3 :

在室溫下攪拌化合物 SD-5.1(50 mg,0.089 mmol)、化合物 FD-2.1(30 mg,0.059 mmol)、DMAP/TsOH鹽(15 mg,0.051 mmol)及EDC•HCl (60 mg,0.31 mmol)於5 mL DCM中之混合物過夜。將反應混合物呈遞至矽膠且藉由急驟層析使用溶離劑DCM/乙酸乙酯(0%至10%乙酸乙酯)純化。收集所需產物峰且減壓濃縮。用乙酸乙酯/甲醇再沈澱所得固體且在空氣中乾燥,得到橙色固體(45 mg,72%)。LCMS (APCI-):C 60H 47BF 5N 3O 9之計算值:1059.33;實驗值:1059。 1H NMR (400 MHz, 二氯甲烷-d2) δ 8.73 (d, J = 7.9 Hz, 1H), 8.66 (d, J = 8.3 Hz, 1H), 8.39 (d, J = 2.2 Hz, 1H), 8.17 (d, J = 8.0 Hz, 1H), 7.86 (dt, J = 11.4, 8.4 Hz, 5H), 7.64 (d, J = 8.3 Hz, 2H), 7.57 (d, J = 8.6 Hz, 1H), 7.43 (d, J = 8.3 Hz, 1H), 7.41 - 7.35 (m, 2H), 7.09 (s, 2H), 4.30 (q, J = 7.1 Hz, 4H), 4.05 (s, 2H), 2.84 (s, 6H), 2.18 (s, 6H), 1.77 (s, 6H), 1.36 (t, J = 7.1 Hz, 6H)。 第二光致發光染料之合成程序 化合物 SD-1 之合成程序 化合物 SD -1.1 (2-(4- 溴苯基 )-4- 苯基 -1 H - 吡咯 ):根據以下文獻程序合成:Synlett, 2016, 27(11), 1738-1742。 化合物 SD-1.2 Compound SD-5.1 (50 mg, 0.089 mmol), compound FD-2.1 (30 mg, 0.059 mmol), DMAP/TsOH salt (15 mg, 0.051 mmol) and EDC·HCl (60 mg, 0.31 mmol) were stirred at room temperature. ) in 5 mL DCM overnight. The reaction mixture was submitted to silica gel and purified by flash chromatography using the eluant DCM/ethyl acetate (0% to 10% ethyl acetate). The desired product peak was collected and concentrated under reduced pressure. The resulting solid was reprecipitated with ethyl acetate/methanol and dried in air to give an orange solid (45 mg, 72%). LCMS (APCI-): Calculated for C 60 H 47 BF 5 N 3 O 9 : 1059.33; found: 1059. 1 H NMR (400 MHz, dichloromethane-d2) δ 8.73 (d, J = 7.9 Hz, 1H), 8.66 (d, J = 8.3 Hz, 1H), 8.39 (d, J = 2.2 Hz, 1H), 8.17 (d, J = 8.0 Hz, 1H), 7.86 (dt, J = 11.4, 8.4 Hz, 5H), 7.64 (d, J = 8.3 Hz, 2H), 7.57 (d, J = 8.6 Hz, 1H), 7.43 (d, J = 8.3 Hz, 1H), 7.41 - 7.35 (m, 2H), 7.09 (s, 2H), 4.30 (q, J = 7.1 Hz, 4H), 4.05 (s, 2H), 2.84 (s , 6H), 2.18 (s, 6H), 1.77 (s, 6H), 1.36 (t, J = 7.1 Hz, 6H). Synthetic procedure of the second photoluminescent dye Synthetic procedure of compound SD-1 Compound SD -1.1 (2-(4- bromophenyl )-4- phenyl -1 H -pyrrole ) : synthesized according to the following literature procedure: Synlett, 2016, 27(11), 1738-1742. Compound SD-1.2 :

在50℃下加熱 SD-1.1(2-(4-溴苯基)-4-苯基-1H-吡咯)(1.0 g,3.36 mmol)、2,4,6-三甲基苯甲醛(0.249 g,1.68 mmol)及對甲苯磺酸(50 mg)於1,2-二氯乙烷(80 mL)中之混合物24 hr。LCMS分析顯示主峰為所需產物,其中m/e += 727。向混合物中添加DDQ (454 mg,2 mmol),且在室溫下攪拌一小時。LCMS分析顯示反應完成,其中一個主峰之m/e -= 724。在0℃下向混合物中添加三乙胺(0.85 mL,6 mmol)、BF 3-乙醚(1.1 mL,9 mmol)。全部在50℃下加熱一小時。添加另一份三乙胺(0.5 mL)及BF3-乙醚(0.5 mL),且在50℃下再加熱混合物一小時。LCMS顯示反應完成,其中主峰之m/e -= 772。用50 mL DCM稀釋混合物,隨後用水洗滌兩次,鹽水洗滌一次,隨後濃縮至100 mL且裝載至矽膠上,藉由急驟層析使用溶離劑己烷/DCM (40%至100% DCM)純化。收集主要所需峰,減壓移除溶劑後,獲得呈紫色固體之所需產物(1.06 g,81.6%產率)。藉由LCMS (APCI)確認:C 42H 31BBr 2F 2N 2之計算值(M-):770.1;實驗值770。 1H NMR (400 MHz, 氯仿-d) δ 7.81 - 7.73 (m, 4H), 7.61 - 7.53 (m, 4H), 6.99 - 6.90 (m, 2H), 6.85 (dd, J = 8.3, 6.9 Hz, 4H), 6.78 - 6.71 (m, 4H), 6.42 (s, 2H), 6.00 (s, 2H), 1.98 (s, 6H), 1.85 (s, 3H)。 化合物 SD-1.3 Heat SD-1.1 (2-(4-bromophenyl)-4-phenyl-1H-pyrrole) (1.0 g, 3.36 mmol), 2,4,6-trimethylbenzaldehyde (0.249 g) at 50°C. , 1.68 mmol) and a mixture of p-toluenesulfonic acid (50 mg) in 1,2-dichloroethane (80 mL) for 24 hr. LCMS analysis showed that the main peak was the desired product with m/e + = 727. DDQ (454 mg, 2 mmol) was added to the mixture and stirred at room temperature for one hour. LCMS analysis showed that the reaction was complete, with one of the main peaks having m/e - = 724. Triethylamine (0.85 mL, 6 mmol), BF 3 -ethyl ether (1.1 mL, 9 mmol) were added to the mixture at 0°C. All heated at 50°C for one hour. Another portion of triethylamine (0.5 mL) and BF3-ethyl ether (0.5 mL) were added and the mixture was heated at 50°C for an additional hour. LCMS showed that the reaction was complete, with m/e of the main peak - = 772. The mixture was diluted with 50 mL DCM and washed twice with water and once with brine, then concentrated to 100 mL and loaded onto silica gel and purified by flash chromatography using the eluant hexane/DCM (40% to 100% DCM). The main desired peaks were collected, and after removing the solvent under reduced pressure, the desired product (1.06 g, 81.6% yield) was obtained as a purple solid. Confirmed by LCMS (APCI): Calculated for C 42 H 31 BBr 2 F 2 N 2 (M-): 770.1; found 770. 1 H NMR (400 MHz, chloroform-d) δ 7.81 - 7.73 (m, 4H), 7.61 - 7.53 (m, 4H), 6.99 - 6.90 (m, 2H), 6.85 (dd, J = 8.3, 6.9 Hz, 4H), 6.78 - 6.71 (m, 4H), 6.42 (s, 2H), 6.00 (s, 2H), 1.98 (s, 6H), 1.85 (s, 3H). Compound SD-1.3 :

使化合物 SD-1.2(160 mg,0.207 mmol)、4-(4,4,5,5-四甲基-1,3,2-二氧雜硼戊環-2-基)苯酚(184 mg,0.828 mmol)、Pd(dppf)Cl 2(16 mg,0.022mol)、碳酸鉀(140 mg,1.01 mmol)於THF/水(8 mL/1 mL)中之混合物脫氣,隨後在80℃下加熱120 min。所得混合物用20 mL DCM稀釋,裝載於矽膠上且藉由急驟層析使用溶離劑DCM/乙酸乙酯(0%至20%乙酸乙酯)純化。收集所需主峰,減壓移除溶劑後,獲得呈深色固體之所需產物(130 mg,79%產率)。 1H NMR (400 MHz, TCE-d2) δ 7.98 - 7.91 (m, 4H), 7.62 - 7.54 (m, 4H), 7.54 - 7.46 (m, 4H), 6.92 - 6.85 (m, 4H), 6.84 (d, J = 2.1 Hz, 2H), 6.82 - 6.74 (m, 4H), 6.73 - 6.66 (m, 4H), 6.46 (s, 2H), 5.92 (s, 2H), 4.88 (s, 2H), 1.92 (s, 6H), 1.78 (s, 3H)。 化合物 SD-1 Compound SD-1.2 (160 mg, 0.207 mmol), 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (184 mg, A mixture of Pd(dppf)Cl 2 (16 mg, 0.022 mol), potassium carbonate (140 mg, 1.01 mmol) in THF/water (8 mL/1 mL) was degassed and heated at 80 °C. 120 minutes. The resulting mixture was diluted with 20 mL DCM, loaded on silica gel and purified by flash chromatography using the eluant DCM/ethyl acetate (0% to 20% ethyl acetate). The desired main peak was collected, and after removing the solvent under reduced pressure, the desired product (130 mg, 79% yield) was obtained as a dark solid. 1 H NMR (400 MHz, TCE-d2) δ 7.98 - 7.91 (m, 4H), 7.62 - 7.54 (m, 4H), 7.54 - 7.46 (m, 4H), 6.92 - 6.85 (m, 4H), 6.84 ( d, J = 2.1 Hz, 2H), 6.82 - 6.74 (m, 4H), 6.73 - 6.66 (m, 4H), 6.46 (s, 2H), 5.92 (s, 2H), 4.88 (s, 2H), 1.92 (s, 6H), 1.78 (s, 3H). Compound SD-1 :

在室溫下攪拌化合物 SD-1.3(80 mg,0.1 mmol)、化合物 SD-1.4(100 mg,0.222 mmol)、DMAP/TsOH鹽(59 mg,0.2 mmol)、DIC (0.15 mL)於6 mL DCM中之混合物過夜,隨後在45℃下攪拌2 hr。將所得混合物裝載於矽膠上且藉由急驟層析使用溶離劑DCM/乙酸乙酯(0%至10%乙酸乙酯)純化。收集所需二偶合產物作為第2主要峰。移除溶劑、用甲醇洗滌且在空氣中乾燥後,獲得呈深色固體之所需產物(100 mg,60%產率)。藉由 1H NMR確認。 1H NMR (400 MHz, d2-TCE) δ 8.49 (dd, J = 16.0, 8.1 Hz, 4H), 7.99 (d, J = 8.2 Hz, 6H), 7.85 (d, J = 8.0 Hz, 2H), 7.63 (dd, J = 8.5, 3.7 Hz, 8H), 7.50 (t, J = 7.8 Hz, 2H), 7.42 - 7.25 (m, 8H), 7.25 - 7.08 (m, 10H), 6.84 (dt, J = 36.5, 7.3 Hz, 6H), 6.70 (d, J = 7.5 Hz, 4H), 6.48 (s, 2H), 5.93 (s, 2H), 2.80 (t, J = 7.7 Hz, 4H), 2.63 (t, J = 7.4 Hz, 4H), 2.11 (t, J = 7.7 Hz, 4H), 1.92 (s, 6H), 1.78 (s, 3H)。 化合物 SD-2 之合成程序 製備化合物 SD-2.1 SD-2.2 SD-2.3 通用程序 化合物 SD-2.1 Stir compound SD-1.3 (80 mg, 0.1 mmol), compound SD-1.4 (100 mg, 0.222 mmol), DMAP/TsOH salt (59 mg, 0.2 mmol), and DIC (0.15 mL) in 6 mL DCM at room temperature. The mixture was left overnight and then stirred at 45°C for 2 hr. The resulting mixture was loaded on silica gel and purified by flash chromatography using the eluant DCM/ethyl acetate (0% to 10% ethyl acetate). The desired secondary coupling product was collected as the second major peak. After removing the solvent, washing with methanol and drying in air, the desired product was obtained as a dark solid (100 mg, 60% yield). Confirmed by 1 H NMR. 1 H NMR (400 MHz, d2-TCE) δ 8.49 (dd, J = 16.0, 8.1 Hz, 4H), 7.99 (d, J = 8.2 Hz, 6H), 7.85 (d, J = 8.0 Hz, 2H), 7.63 (dd, J = 8.5, 3.7 Hz, 8H), 7.50 (t, J = 7.8 Hz, 2H), 7.42 - 7.25 (m, 8H), 7.25 - 7.08 (m, 10H), 6.84 (dt, J = 36.5, 7.3 Hz, 6H), 6.70 (d, J = 7.5 Hz, 4H), 6.48 (s, 2H), 5.93 (s, 2H), 2.80 (t, J = 7.7 Hz, 4H), 2.63 (t, J = 7.4 Hz, 4H), 2.11 (t, J = 7.7 Hz, 4H), 1.92 (s, 6H), 1.78 (s, 3H). Synthetic Procedure for Compound SD-2 General Procedure for Preparing Compounds SD-2.1 , SD-2.2 and SD-2.3 Compound SD-2.1 :

在室溫下向1-苯并環庚酮(10.0 mmol,1.46 mL)於3:1 H 2O/EtOH (32.5 mL)中之溶液中添加NH 2OH·HCl (15.0 mmol,1.04 g)及乙酸鈉(25.0 mmol,2.05 g),且在95℃下攪拌反應混合物1 h。隨後冷卻至室溫,過濾,用水(150 mL)洗滌且凍乾16 h,得到1.64 g呈無色固體之6,7,8,9-四氫-5H-苯并[7]輪烯-5-酮肟(94%產率),其不經進一步純化即用於後續合成步驟中。 To a solution of 1-benzocycloheptanone (10.0 mmol, 1.46 mL) in 3:1 H 2 O/EtOH (32.5 mL) was added NH 2 OH·HCl (15.0 mmol, 1.04 g) and Sodium acetate (25.0 mmol, 2.05 g), and the reaction mixture was stirred at 95 °C for 1 h. Then it was cooled to room temperature, filtered, washed with water (150 mL) and lyophilized for 16 h to obtain 1.64 g of 6,7,8,9-tetrahydro-5H-benzo[7]annene-5- as a colorless solid. The ketoxime (94% yield) was used in the subsequent synthetic step without further purification.

在室溫下向6,7,8,9-四氫-5H-苯并[7]輪烯-5-酮肟(5.71 mmol,1.00 g)於DMSO (9.00 mL)中之溶液中添加KOH (17.1 mmol,959 mg),且將反應混合物加熱至140℃,之後經3 h經由注射泵添加含1,2-二氯乙烷(11.4 mmol,897 µL)之DMSO (2.00 mL)。隨後將混合物冷卻至室溫,用1 M NH 4Cl水溶液(30.0 mL)淬滅且用CH 2Cl 2(3×30.0 mL)萃取。將合併之有機物乾燥(MgSO 4),且減壓濃縮。急驟層析(己烷→9:1,己烷/EtOAc)得到呈262 mg黃色固體之 SD-2.1(25%產率)。 1H NMR (400 MHz, 氯仿-d) δ 8.18 (br s, 1H), 7.34 (dd, J = 7.8, 1.3 Hz, 1H), 7.25 - 7.19 (m, 1H), 7.16 (dd, J = 7.6, 1.6 Hz, 1H), 7.13 - 7.07 (m, 1H), 6.84 (t, J = 2.8 Hz, 1H), 6.17 (t, J = 2.8 Hz, 1H), 2.91 (t, J = 6.8 Hz, 2H), 2.86 - 2.80 (m, 2H), 2.07 - 1.98 (m, 2H); 13C NMR (101 MHz, 氯仿-d) δ 140.4, 131.8, 129.3, 126.8, 125.9, 125.2, 123.2, 121.8, 118.3, 111.1, 34.9, 27.8, 26.7。 化合物 SD-2.3 To a solution of 6,7,8,9-tetrahydro-5H-benzo[7]annen-5-one oxime (5.71 mmol, 1.00 g) in DMSO (9.00 mL) at room temperature was added KOH ( 17.1 mmol, 959 mg), and the reaction mixture was heated to 140°C, then DMSO (2.00 mL) containing 1,2-dichloroethane (11.4 mmol, 897 µL) was added via a syringe pump over 3 h. The mixture was then cooled to room temperature, quenched with 1 M aqueous NH 4 Cl (30.0 mL) and extracted with CH 2 Cl 2 (3×30.0 mL). The combined organics were dried ( MgSO4 ) and concentrated under reduced pressure. Flash chromatography (Hexane → 9:1, Hexane/EtOAc) afforded 262 mg of SD-2.1 as a yellow solid (25% yield). 1 H NMR (400 MHz, chloroform-d) δ 8.18 (br s, 1H), 7.34 (dd, J = 7.8, 1.3 Hz, 1H), 7.25 - 7.19 (m, 1H), 7.16 (dd, J = 7.6 , 1.6 Hz, 1H), 7.13 - 7.07 (m, 1H), 6.84 (t, J = 2.8 Hz, 1H), 6.17 (t, J = 2.8 Hz, 1H), 2.91 (t, J = 6.8 Hz, 2H ), 2.86 - 2.80 (m, 2H), 2.07 - 1.98 (m, 2H); 13 C NMR (101 MHz, chloroform-d) δ 140.4, 131.8, 129.3, 126.8, 125.9, 125.2, 123.2, 121.8, 118. 3, 111.1, 34.9, 27.8, 26.7. Compound SD-2.3 :

100 mL 2頸圓底燒瓶裝配有空氣冷凝管及攪拌棒。向燒瓶中添加化合物 SD-2.11,4,5,6-四氫苯并[6,7]環庚并[1,2-b]吡咯(813.1 mg,4.4 mmol)及 SD-2.24-羥基-2,6-二氯苯甲醛(424.3 mg,2.2 mmol),之後添加無水二氯乙烷(55 ml)。反應混合物用Ar鼓泡30分鐘,隨後添加TFA (4滴)。在室溫下攪拌反應溶液過夜。反應物於冰水浴中冷卻至0℃後,添加四氯對苯醌(731.8 mg,2.98 mmol)。使反應物保持在0℃下30分鐘。隨後在0℃下添加BF 3•OEt 2(3.0 mL,24.1 mmol)及Et 3N (1.9 mL,13.3 mmol)。將反應混合物加熱至50℃,保持3小時。將反應混合物裝載矽膠且藉由急驟層析使用DCM/己烷(0-80-90%)作為溶離劑純化,得到呈金棕色固體之純BODIPY SD-2.3(476.0 mg,36%產率)。MS (APCI):C 33H 24BCl 2F 2N 2O之計算值([M-H]-) = 584 實驗值584。 1H NMR (400 MHz, CDCl3) 8.09 (dd, J = 4.0 Hz, 2.0 Hz, 2H), 7.32 (dddd, J = 13.2 Hz, 7.2 Hz, 7.2 Hz, 2.0 Hz, 4H), 7.22 (dd, J = 6.4 Hz, 2.0 Hz, 2H), 6.99 (s, 2H), 6.43 (s, 2H), 5.77 (bs, 1H), 2.63 (dd, J = 6.8 Hz, 6.8 Hz, 4H), 2.32 (bs, 4H), 2.03 (ddd, J = 14.0 Hz, 6.8 Hz, 6.8 Hz, 4H)。 化合物 SD-2.4 The 100 mL 2-neck round bottom flask is equipped with an air condenser and a stirring rod. Add compounds SD-2.1 1,4,5,6-tetrahydrobenzo[6,7]cyclohepta[1,2-b]pyrrole (813.1 mg, 4.4 mmol) and SD-2.2 4-hydroxy to the flask. -2,6-Dichlorobenzaldehyde (424.3 mg, 2.2 mmol), followed by anhydrous dichloroethane (55 ml). The reaction mixture was bubbled with Ar for 30 min, then TFA (4 drops) was added. The reaction solution was stirred at room temperature overnight. After the reaction was cooled to 0°C in an ice-water bath, tetrachloro-p-benzoquinone (731.8 mg, 2.98 mmol) was added. The reaction was maintained at 0°C for 30 minutes. Then BF 3 •OEt 2 (3.0 mL, 24.1 mmol) and Et 3 N (1.9 mL, 13.3 mmol) were added at 0°C. The reaction mixture was heated to 50°C for 3 hours. The reaction mixture was loaded on silica gel and purified by flash chromatography using DCM/hexane (0-80-90%) as the eluant to obtain pure BODIPY SD-2.3 as a golden brown solid (476.0 mg, 36% yield). MS (APCI): Calculated for C 33 H 24 BCl 2 F 2 N 2 O ([MH]-) = 584 Found 584. 1 H NMR (400 MHz, CDCl3) 8.09 (dd, J = 4.0 Hz, 2.0 Hz, 2H), 7.32 (dddd, J = 13.2 Hz, 7.2 Hz, 7.2 Hz, 2.0 Hz, 4H), 7.22 (dd, J = 6.4 Hz, 2.0 Hz, 2H), 6.99 (s, 2H), 6.43 (s, 2H), 5.77 (bs, 1H), 2.63 (dd, J = 6.8 Hz, 6.8 Hz, 4H), 2.32 (bs, 4H), 2.03 (ddd, J = 14.0 Hz, 6.8 Hz, 6.8 Hz, 4H). Compound SD-2.4 :

使4-溴-1,8-萘二甲酸酐(2.77 g,10 mmol)、4-溴-2-硝基苯酚(3.27 g,15 mmol)之混合物真空脫氣30 min,隨後添加無水NMP (50 mL),之後添加氫氧化鈉(0.2 g,5 mmol)及銅粉(0.318 g,5 mmol)。混合物用氬氣鼓泡20 min,隨後在氬氣氛圍下在180℃下加熱過夜。在冷卻至室溫後,向溶液中逐滴添加50 mL 20%鹽酸水溶液,隨後添加50 mL水。使所得混合物靜置3 hr,隨後過濾以收集沈澱物,真空乾燥,得到4.6 g粗產物。將粗產物分散於30 mL丙酮中且在室溫下攪拌過夜以溶解雜質。過濾且真空乾燥,得到棕黃色固體作為所需產物(3.3 g,80%產率)。LCMS (APCI+):C 18H 9BrNO 6之計算值(M+H) = 413.95;實驗值:414。 1H NMR (400 MHz, TCE-d2) δ 8.70 (dd, J = 8.4, 1.2 Hz, 1H), 8.63 (dd, J = 7.3, 1.2 Hz, 1H), 8.41 (d, J = 8.3 Hz, 1H), 8.24 (d, J = 2.4 Hz, 1H), 7.89 - 7.79 (m, 2H), 7.20 (d, J = 8.7 Hz, 1H), 6.82 (d, J = 8.3 Hz, 1H)。 化合物 SD-2.5 A mixture of 4-bromo-1,8-naphthalenedicarboxylic anhydride (2.77 g, 10 mmol) and 4-bromo-2-nitrophenol (3.27 g, 15 mmol) was vacuum degassed for 30 min, followed by the addition of anhydrous NMP ( 50 mL), then add sodium hydroxide (0.2 g, 5 mmol) and copper powder (0.318 g, 5 mmol). The mixture was bubbled with argon for 20 min and subsequently heated at 180 °C overnight under an argon atmosphere. After cooling to room temperature, 50 mL of 20% aqueous hydrochloric acid solution was added dropwise to the solution, followed by 50 mL of water. The resulting mixture was allowed to stand for 3 hr, then filtered to collect the precipitate and dried under vacuum to obtain 4.6 g of crude product. The crude product was dispersed in 30 mL acetone and stirred at room temperature overnight to dissolve impurities. Filtration and vacuum drying gave a brown solid as the desired product (3.3 g, 80% yield). LCMS (APCI+): Calculated for C 18 H 9 BrNO 6 (M+H) = 413.95; Found: 414. 1 H NMR (400 MHz, TCE-d2) δ 8.70 (dd, J = 8.4, 1.2 Hz, 1H), 8.63 (dd, J = 7.3, 1.2 Hz, 1H), 8.41 (d, J = 8.3 Hz, 1H ), 8.24 (d, J = 2.4 Hz, 1H), 7.89 - 7.79 (m, 2H), 7.20 (d, J = 8.7 Hz, 1H), 6.82 (d, J = 8.3 Hz, 1H). Compound SD-2.5 :

在125℃下加熱化合物 SD-2.4(1.5 g,3.6 mmol)、鐵粉(0.60 g,10.8 mmol)於乙酸(50 mL)中之混合物30 min。冷卻至室溫後,在攪拌同時將100 mL水添加至混合物。將所得混合物過濾且用水洗滌,在空氣及真空中乾燥,得到固體(1.35 g,82%產率)。LCMS (APCI-):C 18H 10BrNO 4之計算值= 382.98;實驗值:383。 1H NMR (400 MHz, DMSO-d6) δ 9.01 - 8.26 (m, 3H), 7.96 (s, 1H), 6.93 (dd, J = 85.2, 36.5 Hz, 4H), 5.54 (s, 2H)。 化合物 SD-2.6 A mixture of compound SD-2.4 (1.5 g, 3.6 mmol), iron powder (0.60 g, 10.8 mmol) in acetic acid (50 mL) was heated at 125°C for 30 min. After cooling to room temperature, 100 mL of water was added to the mixture while stirring. The resulting mixture was filtered and washed with water, dried in air and under vacuum to give a solid (1.35 g, 82% yield). LCMS (APCI-): Calculated for C 18 H 10 BrNO 4 = 382.98; Found: 383. 1 H NMR (400 MHz, DMSO-d6) δ 9.01 - 8.26 (m, 3H), 7.96 (s, 1H), 6.93 (dd, J = 85.2, 36.5 Hz, 4H), 5.54 (s, 2H). Compound SD-2.6 :

將化合物 SD-2.5(2.65 g,6.9 mmol)分散於乙酸(50 mL)/水(10 mL)中且冷卻至0℃。攪拌的同時,添加預冷卻之鹽酸(2.8mL,34.5 mmol),隨後在0℃下逐滴添加含亞硝酸鈉(3.57 g,52 mmol)於15 mL水中之溶液。全部在0℃下攪拌一小時,隨後轉移至另一漏斗中,且在130℃下經一小時時段滴入硫酸銅溶液(12 g,47 mmol,於140 mL水中)。冷卻至室溫後,藉由過濾收集沈澱物,用水(100 mL×3)洗滌,隨後在40℃下於50 mL丙酮中攪拌30 min。過濾,於空氣中乾燥,隨後真空乾燥,得到棕黃色固體(1.76 g,70%產率)。LCMS (APCI+):C 18H 8BrO 4之計算值(M+H) = 366.95;實驗值:367。 1H NMR (400 MHz, d2-TCE) δ 8.51 (dd, J = 12.3, 8.1 Hz, 2H), 8.12 (d, J = 2.3 Hz, 1H), 7.86 (d, J = 7.9 Hz, 1H), 7.60 (dd, J = 8.8, 2.3 Hz, 1H), 7.28 (d, J = 8.3 Hz, 1H), 7.23 (d, J = 8.8 Hz, 1H)。 化合物 SD-2.7 Compound SD-2.5 (2.65 g, 6.9 mmol) was dispersed in acetic acid (50 mL)/water (10 mL) and cooled to 0°C. While stirring, precooled hydrochloric acid (2.8 mL, 34.5 mmol) was added, followed by a solution containing sodium nitrite (3.57 g, 52 mmol) in 15 mL of water dropwise at 0°C. All was stirred at 0°C for one hour, then transferred to another funnel and copper sulfate solution (12 g, 47 mmol in 140 mL water) added dropwise at 130°C over a period of one hour. After cooling to room temperature, the precipitate was collected by filtration, washed with water (100 mL×3), and then stirred in 50 mL acetone at 40°C for 30 min. Filtration, drying in air, then vacuum drying gave a tan solid (1.76 g, 70% yield). LCMS (APCI+): Calculated for C 18 H 8 BrO 4 (M+H) = 366.95; Found: 367. 1 H NMR (400 MHz, d2-TCE) δ 8.51 (dd, J = 12.3, 8.1 Hz, 2H), 8.12 (d, J = 2.3 Hz, 1H), 7.86 (d, J = 7.9 Hz, 1H), 7.60 (dd, J = 8.8, 2.3 Hz, 1H), 7.28 (d, J = 8.3 Hz, 1H), 7.23 (d, J = 8.8 Hz, 1H). Compound SD-2.7 :

在微波反應器中在165℃下加熱化合物 SD-2.6(550 mg,1.5 mmol)、4-(4-胺基苯基)丁酸(537 mg,3 mmol)及DMAP (12.2 mg,0.1 mmol)於10 mL DMF中之混合物2.5 hr。在攪拌的同時將所得溶液滴入50 mL丙酮中。形成沈澱物並過濾,且在60℃下真空烘箱乾燥過夜,得到呈棕黃色固體之所需產物(0.49 g,62%產率)。LCMS (APCI-):C 28H 18BrNO 5之計算值= 527.04;實驗值527。 1H NMR (400 MHz, DMSO-d6) δ 8.54 (d, J = 2.3 Hz, 1H), 8.41 (dd, J = 9.9, 8.0 Hz, 2H), 8.33 (d, J = 7.9 Hz, 1H), 7.71 (dd, J = 8.8, 2.3 Hz, 1H), 7.39 (dd, J = 8.6, 4.2 Hz, 2H), 7.25 (d, J = 8.0 Hz, 2H), 7.17 (d, J = 7.9 Hz, 2H), 2.63 - 2.55 (m, 2H), 2.27 - 2.15 (m, 2H), 1.87 - 1.73 (m, 2H)。 化合物 SD-2.8 Compounds SD-2.6 (550 mg, 1.5 mmol), 4-(4-aminophenyl)butyric acid (537 mg, 3 mmol) and DMAP (12.2 mg, 0.1 mmol) were heated in a microwave reactor at 165°C. Mix in 10 mL DMF for 2.5 hr. The resulting solution was dropped into 50 mL of acetone while stirring. A precipitate formed and was filtered and dried in a vacuum oven at 60°C overnight to give the desired product as a tan solid (0.49 g, 62% yield). LCMS (APCI-): Calculated for C 28 H 18 BrNO 5 = 527.04; found 527. 1 H NMR (400 MHz, DMSO-d6) δ 8.54 (d, J = 2.3 Hz, 1H), 8.41 (dd, J = 9.9, 8.0 Hz, 2H), 8.33 (d, J = 7.9 Hz, 1H), 7.71 (dd, J = 8.8, 2.3 Hz, 1H), 7.39 (dd, J = 8.6, 4.2 Hz, 2H), 7.25 (d, J = 8.0 Hz, 2H), 7.17 (d, J = 7.9 Hz, 2H ), 2.63 - 2.55 (m, 2H), 2.27 - 2.15 (m, 2H), 1.87 - 1.73 (m, 2H). Compound SD-2.8 :

使化合物 SD-2.7(385 mg,0.729 mmol)、苯基硼酸(178 mg,1.45 mmol)、Pd(dppf)Cl2 (36 mg,0.05 mmol)、碳酸鉀(276 mg,2 mmol)於THF/DMF/水(20 L/4 mL/2 mL)之共溶劑中之混合物脫氣,隨後在80℃下加熱過夜。用200 mL乙酸乙酯及50 mL 0.6 N鹽酸水溶液處理混合物。用乙酸乙酯(100 mL×2)萃取水相。收集有機相且用鹽水(100 mL×2)洗滌,經硫酸鈉乾燥,隨後乾燥裝載於矽膠上且藉由急驟層析使用溶離劑DCM/EA (0%至40% EA,含0.1% TFA)純化。收集主要所需溶離份,減壓移除溶劑,得到黃色固體(250 mg,65%產率)。LCMS (APCI-):C 34H 23NO 5之計算值= 525.16;實驗值:525。 1H NMR (400 MHz, TCE-d2) δ 8.55 (dd, J = 19.5, 8.1 Hz, 2H), 8.20 (d, J = 2.1 Hz, 1H), 8.01 (d, J = 8.1 Hz, 1H), 7.72 (dd, J = 8.6, 2.1 Hz, 1H), 7.62 (d, J = 7.3 Hz, 2H), 7.51 - 7.28 (m, 7H), 7.17 (d, J = 8.2 Hz, 2H), 2.72 (t, J = 7.7 Hz, 2H), 2.39 (t, J = 7.3 Hz, 2H), 1.99 (q, J = 7.2 Hz, 2H)。 化合物 SD-2Dissolve compound SD-2.7 (385 mg, 0.729 mmol), phenylboronic acid (178 mg, 1.45 mmol), Pd(dppf)Cl2 (36 mg, 0.05 mmol), and potassium carbonate (276 mg, 2 mmol) in THF/DMF /water (20 L/4 mL/2 mL) in co-solvent was degassed and then heated at 80°C overnight. The mixture was treated with 200 mL of ethyl acetate and 50 mL of 0.6 N aqueous hydrochloric acid. Extract the aqueous phase with ethyl acetate (100 mL×2). The organic phase was collected and washed with brine (100 mL×2), dried over sodium sulfate, then dried and loaded on silica gel and subjected to flash chromatography using the eluant DCM/EA (0% to 40% EA, containing 0.1% TFA) Purification. The main desired fractions were collected and the solvent was removed under reduced pressure to obtain a yellow solid (250 mg, 65% yield). LCMS (APCI-): Calculated for C 34 H 23 NO 5 = 525.16; Found: 525. 1 H NMR (400 MHz, TCE-d2) δ 8.55 (dd, J = 19.5, 8.1 Hz, 2H), 8.20 (d, J = 2.1 Hz, 1H), 8.01 (d, J = 8.1 Hz, 1H), 7.72 (dd, J = 8.6, 2.1 Hz, 1H), 7.62 (d, J = 7.3 Hz, 2H), 7.51 - 7.28 (m, 7H), 7.17 (d, J = 8.2 Hz, 2H), 2.72 (t , J = 7.7 Hz, 2H), 2.39 (t, J = 7.3 Hz, 2H), 1.99 (q, J = 7.2 Hz, 2H). Compound SD-2 :

在室溫下攪拌化合物 SD-2.3(31 mg,0.053 mmol)、化合物 SD-2.8(43 mg,0.082 mmol)、EDC•HCl (100 mg,0.52 mmol)及DMAP/p-TsOH (16 mg,0.054 mmol)於DCM (8 mL)中之混合物過夜。隨後將所得混合物裝載於矽膠上,藉由急驟層析使用溶離劑DCM/乙酸乙酯(0%-5%乙酸乙酯)純化。收集主要紅色溶離份且減壓濃縮至約1 mL,隨後添加10 mL甲醇。過濾所得沈澱物且在空氣中乾燥,得到深紅色固體(41 mg,70.8%產率)。LCMS (APCI-):C 67H 46BCl 2F 2N 3O 5之計算值= 1091.29;實驗值1091。 1H NMR (400 MHz, d2-TCE) δ 8.56 (dd, J = 19.3, 8.1 Hz, 2H), 8.21 (d, J = 2.2 Hz, 1H), 8.02 (d, J = 8.1 Hz, 1H), 7.97 (t, J = 4.7 Hz, 2H), 7.73 (dd, J = 8.6, 2.1 Hz, 1H), 7.63 (dd, J = 7.2, 1.7 Hz, 2H), 7.50 - 7.41 (m, 3H), 7.38 (dd, J = 8.0, 2.2 Hz, 3H), 7.34 - 7.25 (m, 7H), 7.25 - 7.18 (m, 4H), 6.40 (s, 2H), 2.82 (t, J = 7.5 Hz, 2H), 2.67 (t, J = 7.4 Hz, 2H), 2.60 - 2.49 (m, 4H), 2.24 (s, 4H), 2.18 - 2.07 (m, 2H), 2.03 - 1.90 (m, 4H)。 化合物 SD-3 之合成程序 製備 SD-3.2 通用程序 Compound SD-2.3 (31 mg, 0.053 mmol), compound SD-2.8 (43 mg, 0.082 mmol), EDC·HCl (100 mg, 0.52 mmol) and DMAP/p-TsOH (16 mg, 0.054 mmol) in DCM (8 mL) overnight. The resulting mixture was then loaded on silica gel and purified by flash chromatography using the eluent DCM/ethyl acetate (0%-5% ethyl acetate). The main red fraction was collected and concentrated under reduced pressure to about 1 mL, and then 10 mL of methanol was added. The resulting precipitate was filtered and dried in air to give a dark red solid (41 mg, 70.8% yield). LCMS (APCI-): Calculated for C 67 H 46 BCl 2 F 2 N 3 O 5 = 1091.29; found 1091. 1 H NMR (400 MHz, d2-TCE) δ 8.56 (dd, J = 19.3, 8.1 Hz, 2H), 8.21 (d, J = 2.2 Hz, 1H), 8.02 (d, J = 8.1 Hz, 1H), 7.97 (t, J = 4.7 Hz, 2H), 7.73 (dd, J = 8.6, 2.1 Hz, 1H), 7.63 (dd, J = 7.2, 1.7 Hz, 2H), 7.50 - 7.41 (m, 3H), 7.38 (dd, J = 8.0, 2.2 Hz, 3H), 7.34 - 7.25 (m, 7H), 7.25 - 7.18 (m, 4H), 6.40 (s, 2H), 2.82 (t, J = 7.5 Hz, 2H), 2.67 (t, J = 7.4 Hz, 2H), 2.60 - 2.49 (m, 4H), 2.24 (s, 4H), 2.18 - 2.07 (m, 2H), 2.03 - 1.90 (m, 4H). Synthetic procedure of compound SD-3 General Procedure for Preparing SD-3.2

在0-10℃下將AlCl 3(78.0 g,585 mmol,31.9 mL,1.80當量)添加至無水DCM (1.50 L)中。在0℃下攪拌混合物30 min。在0-10℃下於N 2下將化合物 SD-3.1A(88.1 g,585 mmol,72.2 mL,1.80當量)於無水DCM (100 mL)中之混合物添加至該混合物中。將化合物 SD-3.1(82 g,325 mmol,1.00當量)逐份添加至混合物中且在25-30℃下攪拌混合物30 min。在50℃下攪拌混合物12 hr。薄層層析(TLC)(石油醚/乙酸乙酯= 10/1)顯示反應完成。將混合物冷卻至25-30℃且倒入水(1.00 L)中。分離混合物,且用DCM (500 mL×2)萃取水相。合併之有機層經Na 2SO 4乾燥且濃縮。藉由MPLC (100-200目矽膠,DCM)純化產物。獲得呈橙色固體之 SD-3.2(82.0 g,223 mmol,68.8%產率)。LCMS (APCI+),C 25H 18O 3之計算值=366.1;實驗值366。 1H NMR (400 MHz, 氯仿-d) δ 8.57 (dd, J = 8.6, 1.0 Hz, 1H), 8.30 - 8.17 (m, 4H), 7.97 (d, J = 8.1 Hz, 1H), 7.78 (d, J = 8.1 Hz, 1H), 7.73 (d, J = 8.1 Hz, 1H), 7.64 - 7.48 (m, 3H), 3.75 (s, 3H), 3.41 (t, J = 6.5 Hz, 2H), 2.86 (t, J = 6.5 Hz, 2H)。 製備化合物 SD-3.3 通用程序 AlCl 3 (78.0 g, 585 mmol, 31.9 mL, 1.80 equiv) was added to anhydrous DCM (1.50 L) at 0-10 °C. The mixture was stirred at 0 °C for 30 min. A mixture of compound SD-3.1A (88.1 g, 585 mmol, 72.2 mL, 1.80 equiv) in anhydrous DCM (100 mL) was added to the mixture at 0-10 °C under N2 . Compound SD-3.1 (82 g, 325 mmol, 1.00 equiv) was added portionwise to the mixture and the mixture was stirred at 25-30°C for 30 min. The mixture was stirred at 50°C for 12 hr. Thin layer chromatography (TLC) (petroleum ether/ethyl acetate = 10/1) showed the reaction was complete. The mixture was cooled to 25-30°C and poured into water (1.00 L). The mixture was separated and the aqueous phase was extracted with DCM (500 mL×2). The combined organic layers were dried over Na2SO4 and concentrated. The product was purified by MPLC (100-200 mesh silica gel, DCM). SD-3.2 was obtained as an orange solid (82.0 g, 223 mmol, 68.8% yield). LCMS (APCI+), calculated for C 25 H 18 O 3 = 366.1; found 366. 1 H NMR (400 MHz, chloroform-d) δ 8.57 (dd, J = 8.6, 1.0 Hz, 1H), 8.30 - 8.17 (m, 4H), 7.97 (d, J = 8.1 Hz, 1H), 7.78 (d , J = 8.1 Hz, 1H), 7.73 (d, J = 8.1 Hz, 1H), 7.64 - 7.48 (m, 3H), 3.75 (s, 3H), 3.41 (t, J = 6.5 Hz, 2H), 2.86 (t, J = 6.5 Hz, 2H). General procedure for the preparation of compound SD-3.3

在0-10℃下將三氟乙酸(TFA)(231 g,2.03 mol,150 mL,9.90當量)添加至 SD-3.2(75.0 g,204 mmol,1.00當量)於無水DCM (600 mL)中之混合物中。在0-10℃下攪拌混合物30 min。在0-10℃下將三乙基矽烷(Et 3SiH)(71.4 g,614 mmol,98.1 mL,3.00當量)添加至混合物中且在25℃下攪拌混合物16 hr。TLC (石油醚/乙酸乙酯= 3/1)顯示反應完成。濃縮混合物,得到粗產物。在25-30℃下用甲基三級丁基醚(MTBE)(400 mL)濕磨粗產物30 min。過濾混合物,且藉由MTBE (100 mL)洗滌濾餅。真空乾燥濾餅。濃縮母液且藉由矽膠層析(100-200目矽膠,石油醚/乙酸乙酯= 100/1-2/1)純化。獲得呈黃色固體之化合物 SD-3.3(62.0 g,176 mmol,85.9%產率)。 1H NMR (400MHz, CDCl 3) δ 8.27 - 8.08 (m, 4H), 7.91 (d, J = 8.3 Hz, 1H), 7.68 (dd, J = 5.5, 7.9 Hz, 2H), 7.53 (t, J = 8.0 Hz, 1H), 7.48 (dt, J = 1.5, 7.9 Hz, 2H), 7.34 (d, J = 7.7 Hz, 1H), 3.71 (s, 3H), 3.07 (t, J = 7.8 Hz, 2H), 2.47 (t, J = 7.2 Hz, 2H), 2.12 (quin, J = 7.5 Hz, 2H) 製備化合物 3.4 通用程序 Trifluoroacetic acid (TFA) (231 g, 2.03 mol, 150 mL, 9.90 equiv) was added to SD-3.2 (75.0 g, 204 mmol, 1.00 equiv) in anhydrous DCM (600 mL) at 0-10 °C. in the mixture. Stir the mixture at 0-10 °C for 30 min. Triethylsilane ( Et3SiH ) (71.4 g, 614 mmol, 98.1 mL, 3.00 equiv) was added to the mixture at 0-10°C and the mixture was stirred at 25°C for 16 hr. TLC (petroleum ether/ethyl acetate = 3/1) showed the reaction was complete. The mixture was concentrated to give crude product. The crude product was wet-triturated with methyl tertiary butyl ether (MTBE) (400 mL) at 25-30°C for 30 min. The mixture was filtered and the filter cake was washed with MTBE (100 mL). Dry the filter cake under vacuum. The mother liquor was concentrated and purified by silica gel chromatography (100-200 mesh silica gel, petroleum ether/ethyl acetate = 100/1-2/1). Compound SD-3.3 was obtained as a yellow solid (62.0 g, 176 mmol, 85.9% yield). 1 H NMR (400MHz, CDCl 3 ) δ 8.27 - 8.08 (m, 4H), 7.91 (d, J = 8.3 Hz, 1H), 7.68 (dd, J = 5.5, 7.9 Hz, 2H), 7.53 (t, J = 8.0 Hz, 1H), 7.48 (dt, J = 1.5, 7.9 Hz, 2H), 7.34 (d, J = 7.7 Hz, 1H), 3.71 (s, 3H), 3.07 (t, J = 7.8 Hz, 2H ), 2.47 (t, J = 7.2 Hz, 2H), 2.12 (quin, J = 7.5 Hz, 2H) General procedure for the preparation of compound 3.4

在25℃下將 N-溴丁二醯亞胺(NBS)(88.4 g,496 mmol,3.40當量)逐份添加至 SD-3.3(51.5 g,146 mmol,1.00當量)於CHCl 3(2.00 L)中之混合物中。在25℃下攪拌混合物16 hr且保持於暗處。LCMS (ET39890-22-P1A)顯示反應完成。藉由Na 2SO 3(1 N,1.00 L)洗滌混合物。分離混合物,且用DCM (200 mL)萃取水相。濃縮合併之有機層,得到粗產物。藉由矽膠層析(100-200目矽膠,石油醚/乙酸乙酯= 1/0-1/1)純化產物。獲得呈紅棕色油狀物之 SD-3.4(69.2 g,102 mmol,69.9%產率,87.0%純度)。LCMS (APCI+), C 25H 17Br 3O 2之計算值= 585.88;實驗值:589。 製備 SD-3.5 通用程序 Add N- bromosuccinimide (NBS) (88.4 g, 496 mmol, 3.40 equiv) portionwise to SD-3.3 (51.5 g, 146 mmol, 1.00 equiv) in CHCl 3 (2.00 L) at 25 °C. in the mixture. The mixture was stirred at 25°C for 16 hr and kept in the dark. LCMS (ET39890-22-P1A) showed the reaction was complete. The mixture was washed with Na2SO3 (1 N, 1.00 L). The mixture was separated and the aqueous phase was extracted with DCM (200 mL). The combined organic layers were concentrated to obtain crude product. The product was purified by silica gel chromatography (100-200 mesh silica gel, petroleum ether/ethyl acetate = 1/0-1/1). SD-3.4 was obtained as reddish brown oil (69.2 g, 102 mmol, 69.9% yield, 87.0% purity). LCMS (APCI+), calculated for C 25 H 17 Br 3 O 2 = 585.88; found: 589. General Procedure for Preparing SD-3.5

在25℃下將 SD-3.4A(228 g,1.19 mol,151 mL,10.0當量)添加至 SD-3.4(70.0 g,119 mmol,1.00當量)及CuI (113 g,594 mmol,5.00當量)於DMA (490 mL)中之混合物中。在160℃下於N 2下攪拌混合物3 hr。LCMS (ET39890-26-P1A)顯示反應完成。將混合物冷卻至25-30℃且用水(1.50 L)及乙酸乙酯(EtOAc)(1.00 L)稀釋。經由矽藻土墊過濾混合物。藉由EtOAc (500 mL×2)洗滌濾餅。分離合併之濾液,且用EtOAc (500 mL×2)萃取水相。濃縮合併之有機層,得到粗產物。藉由矽膠層析(100-200目矽膠,石油醚/乙酸乙酯= 1/0至1/1)純化產物。獲得呈紅棕色油狀物之 SD-3.5(40.0 g,71.9 mmol,60.5%產率)。 製備化合物 SD-3.6 通用程序 SD-3.4A (228 g, 1.19 mol, 151 mL, 10.0 equiv) was added to SD-3.4 (70.0 g, 119 mmol, 1.00 equiv) and CuI (113 g, 594 mmol, 5.00 equiv) at 25°C. DMA (490 mL) in a mixture. The mixture was stirred at 160 °C under N2 for 3 hr. LCMS (ET39890-26-P1A) showed the reaction was complete. The mixture was cooled to 25-30°C and diluted with water (1.50 L) and ethyl acetate (EtOAc) (1.00 L). The mixture was filtered through a pad of celite. Wash the filter cake by EtOAc (500 mL×2). The combined filtrates were separated and the aqueous phase was extracted with EtOAc (500 mL×2). The combined organic layers were concentrated to obtain crude product. The product was purified by silica gel chromatography (100-200 mesh silica gel, petroleum ether/ethyl acetate = 1/0 to 1/1). SD-3.5 was obtained as reddish brown oil (40.0 g, 71.9 mmol, 60.5% yield). General procedure for the preparation of compound SD-3.6

在25℃下將氫氧化鈉(NaOH)(8.63 g,215 mmol,3.00當量)添加至 SD-3.5(40.0 g,71.9 mmol,1.00當量)於四氫呋喃(THF) (200 mL)、甲醇(MeOH)(200 mL)及H 2O (200 mL)中之混合物中。在25℃下攪拌混合物2 hr。TLC (石油醚/乙酸乙酯= 10/1)顯示反應完成。藉由鹽酸(HCl)溶液(1 N)將混合物酸化至pH = 1-2。濃縮混合物以移除溶劑。將殘餘物用水(150 mL)稀釋且用EtOAc (100 mL×2)萃取。濃縮合併之有機層。藉由矽膠層析(100-200目矽膠,石油醚/乙酸乙酯= 1/0-0/1)純化產物。獲得呈黃色固體之 SD-3.6(26.2 g,48.1 mmol,66.9%產率,99.6%純度)。 1HNMR (400MHz, CDCl 3) δ 8.37 - 7.93 (m, 6H), 7.91 - 7.50 (m, 2H), 3.47 - 3.13 (m, 2H), 2.68 - 2.53 (m, 2H), 2.26 - 2.13 (m, 2H)。 製備化合物 SD-3 之通用程序 化合物 SD-3.7 Add sodium hydroxide (NaOH) (8.63 g, 215 mmol, 3.00 equiv) to SD-3.5 (40.0 g, 71.9 mmol, 1.00 equiv) in tetrahydrofuran (THF) (200 mL), methanol (MeOH) at 25°C. (200 mL) and H 2 O (200 mL). The mixture was stirred at 25°C for 2 hr. TLC (petroleum ether/ethyl acetate = 10/1) showed the reaction was complete. The mixture was acidified to pH = 1-2 by hydrochloric acid (HCl) solution (1 N). The mixture was concentrated to remove solvent. The residue was diluted with water (150 mL) and extracted with EtOAc (100 mL×2). The combined organic layers were concentrated. The product was purified by silica gel chromatography (100-200 mesh silica gel, petroleum ether/ethyl acetate = 1/0-0/1). SD-3.6 was obtained as a yellow solid (26.2 g, 48.1 mmol, 66.9% yield, 99.6% purity). 1 HNMR (400MHz, CDCl 3 ) δ 8.37 - 7.93 (m, 6H), 7.91 - 7.50 (m, 2H), 3.47 - 3.13 (m, 2H), 2.68 - 2.53 (m, 2H), 2.26 - 2.13 (m , 2H). General procedure for the preparation of compound SD-3 Compound SD-3.7 :

向2,6-二氯-4-羥基苯甲醛(0.335 mmol,64 mg)、4-(參(三氟甲基)苝-3-基)丁酸(0.369 mmol,200 mg)及DMAP·pTsOH鹽(0.034 mmol,10 mg)於CH 2Cl 2(1.68 mL)中之溶液中添加DIC (1.34 mmol,210 µL),且在室溫下攪拌反應混合物2 hr。隨後經由矽藻土過濾且減壓濃縮。急驟層析(甲苯)得到187 mg呈黃色固體之 SD-3.7(78%產率)。 1H NMR (400 MHz, 氯仿-d) δ 10.50 - 10.33 (m, 1H), 8.48 - 7.50 (m, 8H), 7.19 - 7.14 (m, 2H), 3.45 - 3.25 (m, 2H), 2.83 - 2.59 (m, 2H), 2.33 - 2.03 (m, 2H)。 化合物 SD-3To 2,6-dichloro-4-hydroxybenzaldehyde (0.335 mmol, 64 mg), 4-(trifluoromethyl)perylene-3-yl)butyric acid (0.369 mmol, 200 mg) and DMAP·pTsOH To a solution of the salt (0.034 mmol, 10 mg) in CH2Cl2 (1.68 mL) was added DIC (1.34 mmol, 210 µL), and the reaction mixture was stirred at room temperature for 2 hr. It was then filtered through celite and concentrated under reduced pressure. Flash chromatography (toluene) afforded 187 mg of SD-3.7 as a yellow solid (78% yield). 1 H NMR (400 MHz, chloroform-d) δ 10.50 - 10.33 (m, 1H), 8.48 - 7.50 (m, 8H), 7.19 - 7.14 (m, 2H), 3.45 - 3.25 (m, 2H), 2.83 - 2.59 (m, 2H), 2.33 - 2.03 (m, 2H). Compound SD-3 :

SD-2.1(0.461 mmol,84 mg)及 SD-3.7(0.210 mmol,150 mg)於CH 2Cl 2(4.50 mL)中之溶液中添加 p-TsOH·H 2O (0.021 mmol,3 mg),且在室溫下攪拌反應混合物1 h。隨後添加DDQ (0.252 mmol,57 mg)且在室溫下攪拌混合物1 h。添加三乙胺(TEA)(1.26 mmol,175 µL),在室溫下攪拌混合物1 h,之後添加BF 3·OEt 2(1.89 mmol,233 µL),且在室溫攪拌混合物2 h。隨後用EtOAc (30.0 mL)稀釋,用3 M HCl (3×30.0 mL)洗滌,乾燥(MgSO 4)且減壓濃縮。急驟層析(4:1甲苯/己烷→甲苯)得到106 mg呈紫色固體之 SD-3(45%產率)。 1H NMR (400 MHz, 二氯甲烷-d2) δ 8.61 - 7.60 (m, 10H), 7.39 - 7.11 (m, 8H), 6.54 - 6.40 (m, 2H), 3.46 - 3.30 (m, 2H), 2.90 - 2.55 (m, 6H), 2.39 - 2.09 (m, 6H), 2.08 - 1.94 (m, 4H)。 化合物 SD-4 之合成程序 化合物 SD -4 合成之通用程序 To a solution of SD-2.1 (0.461 mmol, 84 mg) and SD-3.7 (0.210 mmol, 150 mg) in CH 2 Cl 2 (4.50 mL) was added p- TsOH·H 2 O (0.021 mmol, 3 mg) , and the reaction mixture was stirred at room temperature for 1 h. DDQ (0.252 mmol, 57 mg) was then added and the mixture was stirred at room temperature for 1 h. Triethylamine (TEA) (1.26 mmol, 175 µL) was added and the mixture was stirred at room temperature for 1 h, followed by BF 3 ·OEt 2 (1.89 mmol, 233 µL), and the mixture was stirred at room temperature for 2 h. It was then diluted with EtOAc (30.0 mL), washed with 3 M HCl (3×30.0 mL), dried (MgSO 4 ) and concentrated under reduced pressure. Flash chromatography (4:1 toluene/hexane→toluene) afforded 106 mg of SD-3 as a purple solid (45% yield). 1 H NMR (400 MHz, dichloromethane-d2) δ 8.61 - 7.60 (m, 10H), 7.39 - 7.11 (m, 8H), 6.54 - 6.40 (m, 2H), 3.46 - 3.30 (m, 2H), 2.90 - 2.55 (m, 6H), 2.39 - 2.09 (m, 6H), 2.08 - 1.94 (m, 4H). Synthetic procedure of compound SD-4 General procedure for the synthesis of compound SD-4

10 mL小瓶裝配有攪拌棒。向小瓶中添加化合物 SD-2.3(25.0 mg,0.043 mmol)、 FD-1.5(24.0 mg,0.053 mmol)、EDC•HCl (40.9 mg,0.21 mmol)及DMAP•TsOH (25.6 mg,0.085 mmol),之後添加無水DCM (1.5 ml)。將反應混合物加熱至40℃過夜。在將反應物冷卻至室溫之後,將反應混合物裝載矽膠且藉由急驟層析使用DCM/EtOAc (0-5%)作為溶離劑純化,得到呈深紫色固體之純RL-萘二甲醯亞胺-BODIPY 1605-23-3。用MeOH (10 ml)進一步濕磨固體,得到RL-萘二甲醯亞胺-BODIPY SD-4(21.0 mg,48%產率)。MS (APCI):C 61H 41Cl 2F 2N 3O 5之計算值([M-H]-) = 1015 實驗值:1015。 1H NMR (400 MHz, CDCl3) δ 8.66 (dd, J = 18.4 Hz, 7.6 Hz, 2H), 8.10 (m, 3H), 7.99 (d, J =8.0 Hz, 1H), 7.56 (ddd, J = 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.36 (m, 13H), 7.22 (dd, J = 6.8 Hz, 2.0 Hz, 2H), 6.45 (s, 2H) 2.88 (t, J = 7.6 Hz, 2H), 2.72 (t, J = 7.2 Hz, 2H), 2.63 (m, 4H), 2.20 (m, 6H), 2.04 (ddd, J = 6.8 Hz, 6.8 Hz, 6.8 Hz, 4H)。 化合物 SD-5 之合成程序 化合物 SD-5 合成之通用程序 The 10 mL vial is equipped with a stir bar. Compounds SD-2.3 (25.0 mg, 0.043 mmol), FD-1.5 (24.0 mg, 0.053 mmol), EDC·HCl (40.9 mg, 0.21 mmol) and DMAP·TsOH (25.6 mg, 0.085 mmol) were added to the vial, followed by Add anhydrous DCM (1.5 ml). The reaction mixture was heated to 40°C overnight. After the reaction was cooled to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using DCM/EtOAc (0-5%) as the eluent to obtain pure RL-naphthalenedidine as a dark purple solid. Amine-BODIPY 1605-23-3. Further wet trituration of the solid with MeOH (10 ml) afforded RL-naphthalenedimide-BODIPY SD-4 (21.0 mg, 48% yield). MS (APCI): Calculated value for C 61 H 41 Cl 2 F 2 N 3 O 5 ([MH]-) = 1015 Experimental value: 1015. 1 H NMR (400 MHz, CDCl3) δ 8.66 (dd, J = 18.4 Hz, 7.6 Hz, 2H), 8.10 (m, 3H), 7.99 (d, J =8.0 Hz, 1H), 7.56 (ddd, J = 8.0 Hz, 8.0 Hz, 1.6 Hz, 1H), 7.36 (m, 13H), 7.22 (dd, J = 6.8 Hz, 2.0 Hz, 2H), 6.45 (s, 2H) 2.88 (t, J = 7.6 Hz, 2H ), 2.72 (t, J = 7.2 Hz, 2H), 2.63 (m, 4H), 2.20 (m, 6H), 2.04 (ddd, J = 6.8 Hz, 6.8 Hz, 6.8 Hz, 4H). Synthetic procedure of compound SD-5 General procedure for the synthesis of compound SD-5

25 mL小瓶裝配有攪拌棒。向小瓶中添加化合物 SD-2.3(40.0 mg,0.068 mmol)、1605-99 SD-5.1(77.5 mg,0.137 mmol)、EDC•HCl (65.2 mg,0.340 mmol)及DMAP•TsOH (41.1 mg,0.137 mmol),之後添加無水DCM (4 ml)。將反應混合物加熱至40℃過夜。在將反應物冷卻至室溫之後,將反應混合物裝載矽膠且藉由急驟層析使用DCM/EtOAc (0-4%)作為溶離劑純化,得到呈深藍色固體之純RL-萘二甲醯亞胺-BODIPY SD-5。用MeOH (15 ml)進一步濕磨固體,得到RL-萘二甲醯亞胺-BODIPY SD-5(46.0 mg,60%產率)。MS (APCI):C 66H 41BCl 2F 5N 3O 5之計算值([M-H]-) = 1132 實驗值:1132。 1H NMR (400 MHz, CDCl2CDCl2) δ 8.69 (d, J = 8.0 Hz, 1H), 8.65 (d, J = 8.0 Hz, 1H), 8.30 (d, J = 2.0 Hz, 1H), 8.11 (d, J = 8.0 Hz, 1H), 8.06 (m, 2H), 7.82 (m, 5H), 7.65 (m, 2H), 7.55 (d, J = 8.0 Hz, 1H), 7.39 (m, 9H), 7.30 (m, 2H), 6.48 (s, 2H), 4.07 (s, 2H), 2.63 (m, 4H), 2.33 (bs, 3H), 2.06 (m, 4H)。 製備聚合物溶液 25% PMMA 聚合物溶液製備 The 25 mL vial is equipped with a stir bar. Add compounds SD-2.3 (40.0 mg, 0.068 mmol), 1605-99 SD-5.1 (77.5 mg, 0.137 mmol), EDC·HCl (65.2 mg, 0.340 mmol), and DMAP·TsOH (41.1 mg, 0.137 mmol) to the vial. ), after which anhydrous DCM (4 ml) was added. The reaction mixture was heated to 40°C overnight. After cooling the reaction to room temperature, the reaction mixture was loaded on silica gel and purified by flash chromatography using DCM/EtOAc (0-4%) as the eluent to obtain pure RL-naphthalenedidine as a dark blue solid. Amine-BODIPY SD-5 . Further wet trituration of the solid with MeOH (15 ml) afforded RL-naphthalenedimide-BODIPY SD-5 (46.0 mg, 60% yield). MS (APCI): Calculated for C 66 H 41 BCl 2 F 5 N 3 O 5 ([MH]-) = 1132 Found: 1132. 1 H NMR (400 MHz, CDCl2CDCl2) δ 8.69 (d, J = 8.0 Hz, 1H), 8.65 (d, J = 8.0 Hz, 1H), 8.30 (d, J = 2.0 Hz, 1H), 8.11 (d, J = 8.0 Hz, 1H), 8.06 (m, 2H), 7.82 (m, 5H), 7.65 (m, 2H), 7.55 (d, J = 8.0 Hz, 1H), 7.39 (m, 9H), 7.30 ( m, 2H), 6.48 (s, 2H), 4.07 (s, 2H), 2.63 (m, 4H), 2.33 (bs, 3H), 2.06 (m, 4H). Preparation of polymer solution Preparation of 25% PMMA polymer solution

稱量30 g PMMA聚合物(等級未知),添加至250 mL玻璃瓶中。使用體積量筒量測90 mL環戊酮或甲苯且添加至同一玻璃瓶中。用攪拌棒於攪拌台上攪拌溶液且在50℃下加熱直至完全溶解為止。 製備染料聚合物溶液 Weigh 30 g of PMMA polymer (grade unknown) and add to a 250 mL glass bottle. Use a volumetric cylinder to measure 90 mL of cyclopentanone or toluene and add to the same glass bottle. Stir the solution on a stirring stand with a stirring rod and heat at 50°C until completely dissolved. Preparation of Dye Polymer Solution

0.2 mg FD-1、0.16 mg化合物 SD -3及150 mg聚矽氧顆粒(TSR9000,momentive)。向溶液添加4 mL 25%PMMA溶液。藉由渦旋徹底混合溶液1分鐘,之後進行15分鐘音波處理,隨後於攪拌盤上以適度速度攪拌。 膜製造 個別染料聚合物膜 0.2 mg FD-1 , 0.16 mg compound SD-3 and 150 mg polysiloxane particles (TSR9000, momentive). Add 4 mL of 25% PMMA solution to the solution. Mix the solution thoroughly by vortexing for 1 minute, then sonicate for 15 minutes, then stir on a stir plate at moderate speed. Membrane Fabrication Individual Dye Polymer Films

染料聚合物膜評估基本光學特性。將散射中心(20%矽膠珠粒,平均尺寸2-3 µm)及適當重量之染料溶解於3 mL以上25%PMMA/甲苯溶液中以製成2 mmol/L染料聚合物溶液。藉由渦旋將溶液徹底混合1分鐘,之後進行15分鐘音波處理。用肥皂水清潔若干1''×1''玻璃基板,且鼓風乾燥。隨後將玻璃基板置於旋塗器固持器上,且將染料聚合物溶液倒至玻璃基板上。以設定成1000 RPM之旋轉速度旋塗膜20秒。隨後在室溫下乾燥濕塗膜1小時且在130℃下加熱30分鐘。 綠色及紅色染料聚合物膜 Dye polymer films are evaluated for basic optical properties. Dissolve the scattering center (20% silica beads, average size 2-3 µm) and appropriate weight of dye in more than 3 mL of 25% PMMA/toluene solution to prepare a 2 mmol/L dye polymer solution. The solution was mixed thoroughly by vortexing for 1 minute and then sonicated for 15 minutes. Clean several 1''×1'' glass substrates with soapy water and air dry them. The glass substrate was then placed on the spin coater holder and the dye polymer solution was poured onto the glass substrate. Spin coat the film at a spin speed set to 1000 RPM for 20 seconds. The wet coated film was then dried at room temperature for 1 hour and heated at 130°C for 30 minutes. Green and red dye polymer films

為了將藍光轉換成混合R、G、B色彩之白光,將綠色染料及紅色染料混合至一個膜中。用肥皂水清潔2"x2"玻璃基板且鼓風乾燥。隨後將玻璃基板置於旋塗器固持器上,且將染料聚合物溶液倒於玻璃基板上。以設定成1000 RPM之旋轉速度旋塗膜。隨後在室溫下乾燥濕塗膜1小時且在130℃下加熱30分鐘。一旦膜乾燥,即藉由浸沒於水中5分鐘而自玻璃分離膜。To convert blue light into white light that is a mixture of R, G, and B colors, green dye and red dye are mixed into a film. Clean the 2"x2" glass substrate with soapy water and air dry. The glass substrate was then placed on the spin coater holder and the dye polymer solution was poured onto the glass substrate. Spin coat the film at a spin speed set to 1000 RPM. The wet coated film was then dried at room temperature for 1 hour and heated at 130°C for 30 minutes. Once the membrane was dry, the membrane was detached from the glass by immersion in water for 5 minutes.

藉由改變如下表1中所闡述之第一光致發光染料、第二光致發光染料、散射顆粒及/或聚合物基質材料之重量來製得膜之額外實例。       份數( 重量) 聚合物 PMMA 100 厚度 20-30 µm - 第一光致發光染料 綠色染料 0.01 - 0.06 第二光致發光染料 紅色染料 0.01 - 0.06 散射顆粒 20% 矽膠珠粒, 平均尺寸2-3 µm 25 - 30 1 染料化合物之表徵 吸收及發射光譜分別藉由UV-vis (Shimadzu uv-vis 3600分光光度計)及Fluorolog 3 (Horiba)量測聚合物膜中個別染料之吸收及發射光譜。 染料絕對量子產率 Additional examples of films were made by varying the weight of the first photoluminescent dye, the second photoluminescent dye, the scattering particles, and/or the polymeric matrix material as set forth in Table 1 below. parts( weight) polymer PMMA 100 thickness 20-30 µm - first photoluminescent dye green dye 0.01-0.06 Second photoluminescent dye red dye 0.01-0.06 scattering particles 20% silicone beads, average size 2-3 µm 25-30 Table 1. Characterization of dye compounds. Absorption and emission spectra. The absorption and emission spectra of individual dyes in polymer films were measured by UV-vis (Shimadzu uv-vis 3600 spectrophotometer) and Fluorolog 3 (Horiba) respectively. Dye absolute quantum yield

藉由絕對PL量子產率分光計C11347 (Hamamatsu)在波長450 nm下量測染料膜之絕對量子產率。 藍光轉換 WLC 膜之表徵 LED 背光裝置上的 WLC 膜之外部量子產率 The absolute quantum yield of the dye film was measured by an absolute PL quantum yield spectrometer C11347 (Hamamatsu) at a wavelength of 450 nm. Characterization of Blue Light Converting WLC Films External Quantum Yield of WLC Films on LED Backlight Devices

LED背光顯示器應用上WLC膜之外部量子產率及其他光學特徵使用如 4中所闡述而組態的測試設備測試。BEF代表增亮膜Vikuiti BEF (3M)。DBEF為偏光件/增強膜(3M)。藍色LED側光式背光為發亮裝置之部分。MCPD代表多通道光子偵測(MCPD-9800,Otsuka Electronics)。 基於以下等式計算EQE: 色域 - BT.2020 比率 The external quantum yield and other optical characteristics of WLC films for LED backlight display applications were tested using test equipment configured as illustrated in Figure 4 . BEF stands for Vikuiti BEF (3M) Brightening Film. DBEF is polarizer/enhancement film (3M). The blue LED edge-lit backlight is part of the lighting device. MCPD stands for Multi-Channel Photon Detection (MCPD-9800, Otsuka Electronics). Calculate EQE based on the following equation: Color Gamut - BT.2020 Ratio

色域為某一完全色彩子集。其可由色度圖內之三角形表示。三角形之三個角為原色。顯示器能夠展示之色彩越多,三角形之面積將越大,因此色域越寬。BT.2020為ITU (國際電信聯盟)推薦之UHD投影儀及電視之色域標準。A color gamut is a subset of complete colors. It can be represented by a triangle within the chromaticity diagram. The three angles of a triangle are primary colors. The more colors a monitor can display, the larger the area of the triangle will be, and therefore the wider the color gamut. BT.2020 is the color gamut standard for UHD projectors and TVs recommended by the ITU (International Telecommunications Union).

將藉由 4中所描述之設定量測的光譜轉換成CIE1931色度圖中之色域三角形,且隨後估計三角形面積並除以BT.2020之三角形面積,以獲得本文所提及之BT.2020比率。比率越大,WLC膜之色域更寬越寬。為了實現寬色域,各原色發射光譜形狀應儘可能狹窄。窄光譜形狀的特徵可為發射光譜之FWHM小。 比較實例 The spectrum measured with the setup described in Figure 4 is converted into a gamut triangle in the CIE1931 chromaticity diagram, and the triangle area is then estimated and divided by the triangle area of BT.2020 to obtain the BT mentioned in this article. 2020 ratio. The larger the ratio, the wider and wider the color gamut of the WLC film. In order to achieve a wide color gamut, the emission spectral shape of each primary color should be as narrow as possible. A narrow spectral shape may be characterized by a small FWHM of the emission spectrum. Compare examples

下表2識別比較實例1及2,其為美國專利申請案63/001,924中所揭示之實例。紅色染料SD-X對應於美國專利申請案63/001,924中之SD-1。如表2中可見,實例1具有大色域(94% BT.2020比率),然而其紅色發射光譜之FWHM為68 nm,不會太窄。實例2以較小色域(88% BT.2020比率)之成本得到紅色發射光譜之較窄FWHM。Table 2 below identifies Comparative Examples 1 and 2, which are examples disclosed in US Patent Application No. 63/001,924. Red dye SD-X corresponds to SD-1 in US Patent Application No. 63/001,924. As can be seen in Table 2, Example 1 has a large color gamut (94% BT.2020 ratio), yet its red emission spectrum has a FWHM of 68 nm, which is not too narrow. Example 2 obtains a narrower FWHM of the red emission spectrum at the cost of a smaller color gamut (88% BT.2020 ratio).

實例編號Instance number 綠色染料green dye 紅色染料red dye 發射峰/FWHMEmission peak/FWHM EQEEQE BT.2020BT.2020 比率ratio 1 1 522 nm, 25 nm 642 nm, 68 nm 522nm, 25nm 642 nm, 68 nm 48% 48% 94% 94% 2 2 534 nm, 29 nm 638 nm, 38 nm 534 nm, 29 nm 638 nm, 38 nm 47% 47% 88% 88% surface 22 實例Example

下表4中所列之實例及上表2中所列之比較實例中之膜均藉由上文標題為「膜製造」之章節中所描述之方法製造。表5之實例3至9係使用表2及表3中識別之染料產生。所有綠色發射染料似乎均具有小於25 nm之FWHM,且大部分紅色發射染料具有小於44 nm之FWHM。所有染料具有大於80%之內部量子產率,一些具有大於95%之量子產率。The membranes in the Examples listed in Table 4 below and in the Comparative Examples listed in Table 2 above were all made by the methods described in the section titled "Film Manufacturing" above. Examples 3 through 9 of Table 5 were produced using the dyes identified in Tables 2 and 3. All green-emitting dyes appear to have a FWHM less than 25 nm, and most red-emitting dyes have a FWHM less than 44 nm. All dyes have internal quantum yields greater than 80%, and some have quantum yields greater than 95%.

表5之此等實例3至11之滲透性係藉由上文標題為「藍光轉換WLC膜之表徵」的章節中所描述之方法評估。大部分實例顯示大於51%之EQE,相較於表2之比較實例平均增加10%。此主要係由於表3及表4中之染料之內部量子產率。另外,所有膜具有小於33 nm之綠色發射光譜FWHM及小於63 nm之紅色發射光譜FWHM,以及大於90%之BT.2020比率。 綠色染料 發射峰波長(nm) FWHM (nm) 染料量子產率 FD-1 513 23 96% FD-2 515 24 88% FD-3 513 23 94% 3 紅色染料 發射峰波長(nm) FWHM (nm) 染料量子產率 SD-1 617 44 95% SD-2 611 35 97% SD-3 612 35 84% SD-4 614 35 90% SD-5 608 32 89% 4 綠色染料 紅色染料 發射峰/FWHM EQE BT.2020 比率 實例3 FD-2 (0.7 mM) SD-4 (0.15 mM) 524 nm 26 nm 618 nm 41 nm 53% 93% 實例4 FD-1 (0.4 mM) SD-4 (0.2 mM) 521 nm 24 nm 619 nm 43 nm 52% 93% 實例5 FD-2 (0.7 mM) SD-2 (0.18 mM) 524 nm 25 nm 622 nm 44 nm 52% 92% 實例6 FD-1 (0.4 mM) SD-2 (0.2 mM) 522 nm 25 nm 619 nm 42 nm 53% 93% 實例7 FD-2 (0.7 mM) SD-1 (0.12 mM) 523 nm 27 nm 620 nm 51 nm 52% 91% 實例8 FD-1 (0.4 mM) SD-1 (0.1 mM) 521 nm 25 nm 621 nm 50 nm 51% 91% 實例9 FD-2 (0.7 mM) SD-3 (0.25 mM) 525 nm 32 nm 639 nm 63 nm 40% 94% 實例10 FD-1 (0.4 mM) SD-3 (0.25 mM) 521 nm 25 nm 621 nm 50 nm 49% 94% 實例11 FD-3 (0.4 mM) SD-5 (0.2 mM) 522 nm 24 nm 621 nm 45 nm 54% 94% 5 相關申請案之交互參考 The permeability of Examples 3 to 11 of Table 5 was evaluated by the method described above in the section titled "Characterization of Blue Light Converting WLC Films." Most examples show an EQE greater than 51%, an average increase of 10% compared to the comparative examples in Table 2. This is mainly due to the internal quantum yield of the dyes in Tables 3 and 4. In addition, all films have a green emission spectrum FWHM less than 33 nm and a red emission spectrum FWHM less than 63 nm, and a BT.2020 ratio greater than 90%. green dye Emission peak wavelength (nm) FWHM (nm) dye quantum yield FD-1 513 twenty three 96% FD-2 515 twenty four 88% FD-3 513 twenty three 94% Table 3 red dye Emission peak wavelength (nm) FWHM (nm) dye quantum yield SD-1 617 44 95% SD-2 611 35 97% SD-3 612 35 84% SD-4 614 35 90% SD-5 608 32 89% Table 4 membrane green dye red dye Emission peak/FWHM EQE BT.2020 Ratio Example 3 FD-2 (0.7 mM) SD-4 (0.15 mM) 524 nm 26 nm 618 nm 41 nm 53% 93% Example 4 FD-1 (0.4 mM) SD-4 (0.2 mM) 521 nm 24 nm 619 nm 43 nm 52% 93% Example 5 FD-2 (0.7 mM) SD-2 (0.18 mM) 524 nm 25 nm 622 nm 44 nm 52% 92% Example 6 FD-1 (0.4 mM) SD-2 (0.2 mM) 522 nm 25 nm 619 nm 42 nm 53% 93% Example 7 FD-2 (0.7 mM) SD-1 (0.12 mM) 523 nm 27 nm 620 nm 51 nm 52% 91% Example 8 FD-1 (0.4 mM) SD-1 (0.1 mM) 521 nm 25 nm 621 nm 50 nm 51% 91% Example 9 FD-2 (0.7 mM) SD-3 (0.25 mM) 525 nm 32 nm 639 nm 63 nm 40% 94% Example 10 FD-1 (0.4 mM) SD-3 (0.25 mM) 521 nm 25 nm 621 nm 50 nm 49% 94% Example 11 FD-3 (0.4 mM) SD-5 (0.2 mM) 522 nm 24 nm 621 nm 45 nm 54% 94% Table 5 Cross-reference of related applications

本申請案主張2021年11月12日申請之美國臨時申請案第63/278,923號之優先權,該臨時申請案以全文引用之方式併入本文中。This application claims priority to U.S. Provisional Application No. 63/278,923, filed on November 12, 2021, which is incorporated herein by reference in its entirety.

10:顯示裝置 12:光源 14:背部反射器 16:波長轉換膜 18:遮罩 20:觀看者 22:增亮膜 24:雙重增亮膜 10:Display device 12:Light source 14:Back reflector 16:Wavelength conversion film 18: Mask 20:Viewer 22:Brightening film 24:Double brightening film

1為併入有本文所描述之改良WLC膜的顯示裝置之實施例之示意圖。 2為併入有本文所描述之改良WLC膜的顯示裝置之實施例之示意圖。 3為併入有本文所描述之改良WLC膜的顯示裝置之實施例之示意圖。 4為包括本文所描述之膜實施例的測試組態之示意圖。 Figure 1 is a schematic diagram of an embodiment of a display device incorporating a modified WLC film described herein. Figure 2 is a schematic diagram of an embodiment of a display device incorporating a modified WLC film described herein. Figure 3 is a schematic diagram of an embodiment of a display device incorporating a modified WLC film described herein. Figure 4 is a schematic diagram of a test configuration including film embodiments described herein.

10:顯示裝置 10:Display device

12:光源 12:Light source

16:波長轉換膜 16:Wavelength conversion film

20:觀看者 20:Viewer

Claims (17)

一種波長轉換膜,其包含: 聚合物基質; 第一光致發光染料,該第一光致發光染料吸收藍色波長光且以半高寬小於40 nm之發射光譜發射綠色波長光; 第二光致發光染料,該第二光致發光染料吸收藍色或綠色波長光且以半高寬小於55 nm之發射光譜發射紅色波長光;及 光散射中心, 其中該第一光致發光染料、該第二光致發光染料及該光散射中心安置於該聚合物基質內。 A wavelength conversion film containing: polymer matrix; a first photoluminescent dye that absorbs blue wavelength light and emits green wavelength light with an emission spectrum with a half-maximum width less than 40 nm; a second photoluminescent dye that absorbs blue or green wavelength light and emits red wavelength light with an emission spectrum with a half-maximum width less than 55 nm; and light scattering center, The first photoluminescent dye, the second photoluminescent dye and the light scattering center are arranged in the polymer matrix. 如請求項1之波長轉換膜,其中該第一光致發光染料包含視情況經取代之BODIPY基團、連接基團及視情況經取代之異喹啉基。The wavelength conversion film of claim 1, wherein the first photoluminescent dye includes an optionally substituted BODIPY group, a linking group and an optionally substituted isoquinolinyl group. 如請求項2之波長轉換膜,其中該第一光致發光染料為: ,或 The wavelength conversion film of claim 2, wherein the first photoluminescent dye is: ,or . 如請求項1之波長轉換膜,其中該第一光致發光染料包含視情況經取代之BODIPY基團、連接基團及視情況經取代之萘二甲酸醯亞胺基。The wavelength conversion film of claim 1, wherein the first photoluminescent dye includes an optionally substituted BODIPY group, a linking group and an optionally substituted naphthalenedicarboxylic acid imide group. 如請求項4之波長轉換膜,其中該第一光致發光染料為: The wavelength conversion film of claim 4, wherein the first photoluminescent dye is: . 如請求項1之波長轉換膜,其中該第二光致發光染料包含視情況經取代之BODIPY基團、連接基團及視情況經取代之異喹啉基。The wavelength conversion film of claim 1, wherein the second photoluminescent dye includes an optionally substituted BODIPY group, a linking group and an optionally substituted isoquinolinyl group. 如請求項6之波長轉換膜,其中該第二光致發光染料為: The wavelength conversion film of claim 6, wherein the second photoluminescent dye is: . 如請求項1之波長轉換膜,其中該第二光致發光染料包含視情況經取代之BODIPY基團、連接基團及視情況經取代之萘二甲醯亞胺基。The wavelength conversion film of claim 1, wherein the second photoluminescent dye includes an optionally substituted BODIPY group, a linking group and an optionally substituted naphthalene dimethylimide group. 如請求項8之波長轉換膜,其中該第二光致發光染料為: The wavelength conversion film of claim 8, wherein the second photoluminescent dye is: . 如請求項1之波長轉換膜,其中該第二光致發光染料包含視情況經取代之BODIPY基團、連接基團及視情況經取代之苝基。The wavelength conversion film of claim 1, wherein the second photoluminescent dye includes an optionally substituted BODIPY group, a linking group and an optionally substituted perylene group. 如請求項8之波長轉換膜,其中該第二光致發光染料為: The wavelength conversion film of claim 8, wherein the second photoluminescent dye is: . 如請求項1至11中任一項之波長轉換膜,其中該波長轉換膜具有大於80%之內部量子產率。The wavelength conversion film of any one of claims 1 to 11, wherein the wavelength conversion film has an internal quantum yield greater than 80%. 如請求項1至11中任一項之波長轉換膜,其中該波長轉換膜具有大於50%之外部量子產率。The wavelength conversion film of any one of claims 1 to 11, wherein the wavelength conversion film has an external quantum yield greater than 50%. 如請求項1至11中任一項之波長轉換膜,其中該波長轉換膜具有大於BT.2020標準之90%的色域。The wavelength conversion film of any one of claims 1 to 11, wherein the wavelength conversion film has a color gamut greater than 90% of the BT.2020 standard. 如請求項1至11中任一項之波長轉換膜,其中該波長轉換膜具有10 µm與40 µm之間的厚度。The wavelength conversion film of any one of claims 1 to 11, wherein the wavelength conversion film has a thickness between 10 µm and 40 µm. 一種發光裝置,其包含如請求項1至11中任一項之波長轉換膜。A light-emitting device comprising the wavelength conversion film according to any one of claims 1 to 11. 一種具有藍色光源之背光裝置,該裝置包含如請求項1至11中任一項之波長轉換膜。A backlight device with a blue light source, the device includes the wavelength conversion film according to any one of claims 1 to 11.
TW111143158A 2021-11-12 2022-11-11 Wavelength conversion film and display device including the same TW202334720A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163278923P 2021-11-12 2021-11-12
US63/278,923 2021-11-12

Publications (1)

Publication Number Publication Date
TW202334720A true TW202334720A (en) 2023-09-01

Family

ID=87419313

Family Applications (1)

Application Number Title Priority Date Filing Date
TW111143158A TW202334720A (en) 2021-11-12 2022-11-11 Wavelength conversion film and display device including the same

Country Status (2)

Country Link
TW (1) TW202334720A (en)
WO (1) WO2023158509A2 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10962705B2 (en) * 2015-01-31 2021-03-30 Lg Chem, Ltd. Color conversion film and back light unit and display apparatus comprising the same
EP3810719B1 (en) * 2018-06-22 2022-05-11 Basf Se Photostable cyano-substituted boron-dipyrromethene dye as green emitter for display and illumination applications
WO2020210761A1 (en) 2019-04-12 2020-10-15 Nitto Denko Corporation Boron-containing cyclic emissive compounds and color conversion film containing the same

Also Published As

Publication number Publication date
WO2023158509A2 (en) 2023-08-24
WO2023158509A3 (en) 2023-11-09

Similar Documents

Publication Publication Date Title
EP3361294B1 (en) Color conversion composition, color conversion sheet, and light source unit, display, lighting system, backlight unit, led chip and led package containing same
JP6822554B2 (en) Color conversion composition, color conversion sheet and light source unit including it, display and lighting equipment
EP3418781A1 (en) Color conversion sheet, light source unit comprising same, display and lighting device
JP6690721B2 (en) Color conversion composition, color conversion film and light source unit, display and illumination including the same
JP7451560B2 (en) Boron-containing cyclic luminescent compound and color conversion film containing the same
JP7290047B2 (en) Color conversion composition, color conversion sheet, and light source unit, display and lighting device containing the same
TWI760152B (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
TW202214430A (en) Color conversion sheet and light source unit including same, display, and lighting device
TWI659071B (en) Coumarin-based green dye contains side chain vinyl triphenylamine
TW202334720A (en) Wavelength conversion film and display device including the same
TW201823342A (en) Light conversion film containing the AIE nature green dye
TWI784458B (en) Improved wavelength conversion film
TWI823263B (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
TW202246456A (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
TWI764521B (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
JP2020507599A (en) Nitrogen-containing ring compound and color conversion film containing the same
WO2024081802A1 (en) Wavelength conversion film and display device including the same
TW202330556A (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
TW202246457A (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
TW202140749A (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
WO2023158976A1 (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
WO2023158977A1 (en) Boron-containing cyclic emissive compounds and color conversion film containing the same
KR20240065040A (en) Boron-containing cyclic luminescent compound and color conversion film containing the same
CN117063288A (en) Boron-containing cyclic light-emitting compound and color conversion film comprising same